Maryland | 1-12993 | 95-4502084 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||
385 East Colorado Boulevard, Suite 299 | ||
Pasadena, California | 91101 | |
(Address of principal executive offices) | (Zip Code) | |
ALEXANDRIA REAL ESTATE EQUITIES, INC. | ||||
February 4, 2019 | By: | /s/ Joel S. Marcus | ||
Joel S. Marcus | ||||
Executive Chairman | ||||
By: | /s/ Stephen A. Richardson | |||
Stephen A. Richardson | ||||
Co-Chief Executive Officer | ||||
By: | /s/ Peter M. Moglia | |||
Peter M. Moglia | ||||
Co-Chief Executive Officer and Co-Chief Investment Officer | ||||
By: | /s/ Dean A. Shigenaga | |||
Dean A. Shigenaga | ||||
Co-President and Chief Financial Officer | ||||

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2019 | ||
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2019 | i | |

(1) | See definitions of “Annual Rental Revenue,” “Class A Properties and AAA Locations,” and “Investment-Grade or Publicly Traded Large Cap Tenants” in the “Definitions and Reconciliations” section of our Supplemental Information for additional information. As of December 31, 2018, annual rental revenue solely from investment-grade tenants within our overall tenant base and within our top 20 tenants was 47% and 76%, respectively. |
![]() | |
Table of Contents | |
December 31, 2018 | |
EARNINGS PRESS RELEASE | Page |
SUPPLEMENTAL INFORMATION | |
Internal Growth | |
SUPPLEMENTAL INFORMATION (continued) | Page |
External Growth / Investments in Real Estate | |
New Class A Development and Redevelopment Properties: | |
Balance Sheet Management | |
Definitions and Reconciliations | |
This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Please see page 8 of this Earnings Press Release and our Supplemental Information for further information. |
This document is not an offer to sell or a solicitation to buy securities of Alexandria Real Estate Equities, Inc. Any offers to sell or solicitations to buy our securities shall be made only by means of a prospectus approved for that purpose. Unless otherwise indicated, the “Company,” “Alexandria,” “ARE,” “we,” “us,” and “our” refer to Alexandria Real Estate Equities, Inc. and our consolidated subsidiaries. |
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2019 | iii | |

4Q18 | 4Q17 | 2018 | 2017 | ||||||||||||
Total revenues: | |||||||||||||||
In millions | $ | 340.5 | $ | 298.8 | $ | 1,327.5 | $ | 1,128.1 | |||||||
Growth | 13.9% | 17.7% | |||||||||||||
Net (loss) income attributable to Alexandria’s common stockholders – diluted: | |||||||||||||||
In millions | $ | (31.7 | ) | $ | 36.8 | $ | 364.0 | $ | 145.4 | ||||||
Per share | $ | (0.30 | ) | $ | 0.38 | $ | 3.52 | $ | 1.58 | ||||||
Funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted: | |||||||||||||||
In millions | $ | 178.0 | $ | 147.0 | $ | 682.0 | $ | 554.5 | |||||||
Per share | $ | 1.68 | $ | 1.53 | $ | 6.60 | $ | 6.02 | |||||||
On January 1, 2018, we adopted a new accounting standard that requires us, on a prospective basis, to present certain equity investments at fair value with changes in fair value reflected in earnings. See “Items Included in Net (Loss) Income Attributable to Alexandria’s Common Stockholders” on the next page for additional information. | |||||||||||||||
• | Unrealized losses of $94.9 million and unrealized gains of $99.6 million recognized in 4Q18 and 2018, respectively; and |
• | Realized gains of $11.3 million and $37.1 million recognized in 4Q18 and 2018, respectively. |
• | Net operating income (cash basis) of $878.0 million for 4Q18 annualized, up $184.9 million, or 26.7%, compared to 4Q17 annualized |
• | Same property net operating income growth: |
• | 3.8% and 7.6% (cash basis) for 4Q18, compared to 4Q17 |
• | 3.7% and 9.2% (cash basis) for 2018, compared to 2017. Growth of 9.2% (cash basis) represents the highest annual increase during the past 10 years. |
• | Continued strong leasing activity and rental rate growth in light of modest contractual lease expirations at the beginning of 2018 and a highly leased value-creation pipeline: |
4Q18 | 2018 | |||||
Total leasing activity – RSF | 1,558,064 | 4,721,692 | ||||
Lease renewals and re-leasing of space: | ||||||
RSF (included in total leasing activity above) | 650,540 | 2,088,216 | ||||
Rental rate increases | 17.4% | 24.1% | ||||
Rental rate increases (cash basis) | 11.4% | 14.1% | ||||
Property | Submarket | RSF | Leased | Tenant | ||||
4Q18: | ||||||||
213 East Grand Avenue | South San Francisco | 300,930 | 100% | Merck & Co., Inc. | ||||
9625 Towne Centre Drive | University Town Center | 163,648 | 100% | Takeda Pharmaceutical Company Ltd. | ||||
January 2019: | ||||||||
399 Binney Street | Cambridge | 123,403 | 100% | Three life science entities | ||||
![]() | |
Fourth Quarter and Year Ended December 31, 2018, Financial and Operating Results (continued) | |
December 31, 2018 | |
Items included in net (loss) income attributable to Alexandria’s common stockholders: | |||||||||||||||||||||||||||||||||
(In millions, except per share amounts) | 4Q18 | 4Q17 | 4Q18 | 4Q17 | 2018 | 2017 | 2018 | 2017 | |||||||||||||||||||||||||
Amount | Per Share – Diluted | Amount | Per Share – Diluted | ||||||||||||||||||||||||||||||
Unrealized (losses) gains on non-real estate investments(1) | $ | (94.9 | ) | $ | — | $ | (0.89 | ) | $ | — | $ | 99.6 | $ | — | $ | 0.96 | $ | — | |||||||||||||||
Realized gains on non-real estate investments | 6.4 | — | 0.06 | — | 14.7 | — | 0.14 | — | |||||||||||||||||||||||||
Gain on sales of real estate | 8.7 | — | 0.08 | — | 44.4 | (2 | ) | 14.5 | (2 | ) | 0.43 | 0.15 | |||||||||||||||||||||
Impairment of: | |||||||||||||||||||||||||||||||||
Real estate | — | — | — | — | (6.3 | ) | (0.2 | ) | (0.06 | ) | — | ||||||||||||||||||||||
Non-real estate investments | (5.5 | ) | (3.8 | ) | (0.05 | ) | (0.04 | ) | (5.5 | ) | (8.3 | ) | (0.05 | ) | (0.09 | ) | |||||||||||||||||
Early extinguishment of debt: | |||||||||||||||||||||||||||||||||
Loss | — | (2.8 | ) | — | (0.03 | ) | (1.1 | ) | (3.5 | ) | (0.01 | ) | (0.03 | ) | |||||||||||||||||||
Gain | — | — | — | — | 0.8 | (2 | ) | — | 0.01 | — | |||||||||||||||||||||||
Preferred stock redemption charge | (4.2 | ) | — | (0.04 | ) | — | (4.2 | ) | (11.3 | ) | (0.04 | ) | (0.12 | ) | |||||||||||||||||||
Allocation to unvested restricted stock awards | — | 0.1 | — | — | (2.2 | ) | 0.1 | (0.02 | ) | — | |||||||||||||||||||||||
Total | $ | (89.5 | ) | $ | (6.5 | ) | $ | (0.84 | ) | $ | (0.07 | ) | $ | 140.2 | $ | (8.7 | ) | $ | 1.36 | $ | (0.09 | ) | |||||||||||
Weighted-average shares of common stock outstanding for calculation of earnings per share – diluted | 106.0 | 95.9 | 103.3 | 92.1 | |||||||||||||||||||||||||||||
(1) See “Investments” on page 45 of our Supplemental Information for additional information. (2) Includes our share of amounts attributable to our unconsolidated real estate joint ventures. See “Joint Venture Financial Information” in our Supplemental Information for additional information. | |||||||||||||||||||||||||||||||||
Percentage of annual rental revenue in effect from: | ||||
Investment-grade or publicly traded large cap tenants | 52 | % | ||
Class A properties in AAA locations | 77 | % | ||
Occupancy of operating properties in North America | 97.3 | % | ||
Operating margin | 71 | % | ||
Adjusted EBITDA margin | 69 | % | ||
Weighted-average remaining lease term: | ||||
All tenants | 8.6 | years | ||
Top 20 tenants | 12.3 | years | ||
• | $18.4 billion of total market capitalization |
• | $2.4 billion of liquidity |
• | 3% unhedged variable-rate debt as a percentage of total debt |
4Q18 | ||||||
Quarter | Trailing 12 | 4Q19 | ||||
Annualized | Months | Goal | ||||
Net debt to Adjusted EBITDA | 5.4x | 5.6x | Less than or equal to 5.3x | |||
Fixed-charge coverage ratio | 4.1x | 4.2x | Greater than 4.0x | |||
Current and future value-creation pipeline as a percentage of gross investments in real estate in North America | 11% | N/A | 8% to 12% | |||
• | During 4Q18, we executed additional interest rate hedge agreements with a notional of $250.0 million and a weighted-average fixed pay rate of 2.84%, effective March 29, 2019. |
• | During 4Q18, we repurchased, in privately negotiated transactions, 402,000 shares of our 7.00% Series D cumulative convertible preferred stock for $14.0 million, or $34.77 per share, and recognized a preferred stock redemption charge of $4.2 million. |
• | In November 2018, we exercised our option to extend the maturity date of our secured construction loan for our properties at 50 and 60 Binney Street in our Cambridge submarket to January 28, 2020. |
• | In December 2018, we settled the remaining 5.2 million shares from our January 2018 forward equity sales agreements and received proceeds of $608.1 million, or $116.97 per share, net of underwriting discounts and adjustments as provided for in the agreements. |
• | During 4Q18, there was no activity under our “at the market” common stock offering programs. As of December 31, 2018, the remaining aggregate amount available under our current programs for future sales of common stock is $658.7 million. |
![]() | |
Fourth Quarter and Year Ended December 31, 2018, Financial and Operating Results (continued) | |
December 31, 2018 | |
• | Our philanthropy and volunteerism efforts focus on providing mission-critical support to non-profit organizations doing impactful work in the areas of medical research, STEM education, military support services, and local communities. In 2018, our team members volunteered more than 2,600 hours to support over 250 non-profit organizations across the country. |
• | We value both the health and wellness of our team members as well as supporting organizations on the leading edge of medical innovation. In November 2018, we were honored to support 49 team members in the New York City Marathon in order to benefit Memorial Sloan Kettering Cancer Center. |
• | In November 2018, Robin Hood, New York City’s largest poverty-fighting organization, held its annual investor conference, at which Joel S. Marcus, our executive chairman and founder, curated and moderated the “Go Long on Ag” panel that focused on the critical need for agricultural innovation to provide more nutritious food in order to feed a rapidly growing population. |
• | In November 2018, Ari Frankel, our assistant vice president of sustainability and high performance buildings, was elected 2019 Chair of Nareit’s Real Estate Sustainability Council. |
• | In January 2019, we were recognized as the most active biopharma investor by new deal volume in 2017-2018 by Silicon Valley Bank in its “Trends in Healthcare Investments and Exits 2019” report and ranked by Forbes as the top venture capital investor in the healthcare sector by U.S.-based deal volume in 2018. |
• | In January 2019, we repaid early one secured note payable aggregating $106.7 million, originally due in 2020 and that bore interest at 7.75%, and recognized a loss on early extinguishment of debt of $7.1 million, including the write-off of unamortized loan fees. |
• | In January 2019, we repurchased, in privately negotiated transactions, 275,000 shares of our 7.00% Series D cumulative convertible preferred stock for $9.2 million, or $33.60 per share, and recognized a preferred stock redemption charge of $2.6 million. As of February 4, 2019, 2.3 million shares of our Series D Convertible Preferred Stock were outstanding at a book value aggregating $57.5 million. |
• | In January 2019, we completed the acquisition of five properties in key submarkets with value-add operating properties. See “Acquisitions” in this Earnings Press Release for additional information. |
Select 2018 Highlights | ![]() | |
December 31, 2018 | ||

(1) | Rental rate increase of 14.1% (cash basis) represents our highest annual increase during the past 10 years. |
(2) | Leasing activity aggregating 4.7 million RSF for 2018 represents the second highest annual leasing activity in our history. |
Acquisitions | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Property | Submarket/Market | Date of Purchase | Number of Properties | Operating Occupancy | Square Footage | Purchase Price | ||||||||||||||||
Future Development | Active Redevelopment | Operating With Future Development/Redevelopment | ||||||||||||||||||||
4Q18 Acquisitions: | ||||||||||||||||||||||
Alexandria Life Science Factory at Long Island City(1) | New York City/New York City | 10/9/18 | 1 | 100% | — | 140,098 | 36,661 | $ | 75,000 | |||||||||||||
10260 Campus Point Drive and 4161 Campus Point Court | University Town Center/ San Diego | 12/28/18 | 2 | 100% | 378,355 | (2) | — | 269,048 | (2) | 15,000 | (3) | |||||||||||
3 | 378,355 | 140,098 | 305,709 | $ | 90,000 | |||||||||||||||||
(1) | Refer to the “New Class A Development and Redevelopment Properties: Summary of Pipeline” on page 41 of our Supplemental Information for additional information. |
(2) | We acquired two buildings adjacent to our Campus Pointe by Alexandria campus aggregating 269,048 RSF, comprising 109,164 RSF at 10260 Campus Point Drive and 159,884 RSF at 4161 Campus Point Court which are 100% leased through 2022. At lease expiration, 10260 Campus Point Drive will be redeveloped and expanded into a 176,455 RSF Class A building, which is pre-leased 100% for 15 years with the target delivery in 2021. 4161 Campus Point Court will support future development aggregating 201,900 RSF through one or more Class A buildings at our Campus Pointe by Alexandria campus. |
(3) | Total purchase price of $80.0 million was paid in two installments, $15.0 million in December 2018 and $65.0 million in January 2019. |
Property | Submarket/Market | Date of Purchase | Number of Properties | Operating Occupancy | Square Footage | Unlevered Yields | Purchase Price | ||||||||||||||||||||
Operating With Future Development/ Redevelopment | Operating | Initial Stabilized | Initial Stabilized (Cash) | ||||||||||||||||||||||||
2019 Acquisitions: | |||||||||||||||||||||||||||
3170 Porter Drive | Greater Stanford/ San Francisco | 1/10/19 | 1 | 100% | — | 98,626 | 7.5 | % | 5.1 | % | $ | 100,250 | |||||||||||||||
Shoreway Science Center | Greater Stanford/ San Francisco | 1/10/19 | 2 | 100% | — | 82,462 | 7.2 | % | 5.5 | % | 73,200 | ||||||||||||||||
10260 Campus Point Drive and 4161 Campus Point Court | University Town Center/San Diego | N/A | N/A | N/A | N/A | N/A | (1 | ) | (1 | ) | 65,000 | (2) | |||||||||||||||
3911 and 3931 Sorrento Valley Boulevard | Sorrento Mesa/San Diego | 1/9/19 | 2 | 100% | 53,220 | — | 7.2 | % | 6.6 | % | 23,060 | ||||||||||||||||
Remaining targeted acquisitions | 368,490 | ||||||||||||||||||||||||||
2019 guidance midpoint | $ | 630,000 | |||||||||||||||||||||||||
(1) | We expect to provide total estimated costs and related yields in the future upon the commencement of development and redevelopment. |
(2) | See footnote 3 above. |
Dispositions and Sale of Partial Joint Venture Interest | ![]() |
December 31, 2018 | |
(Dollars in thousands, except per RSF amounts) | |
Property | Submarket/Market | Date of Sale | RSF | Sales Price | Sales Price per RSF | Gain | |||||||||||||
4Q18 Disposition: | |||||||||||||||||||
1300 Quince Orchard Boulevard | Gaithersburg/Maryland | 12/13/18 | 54,874 | $ | 14,441 | (1) | $ | 263 | $ | 8,704 | |||||||||
2019 Sale of Partial Joint Venture Interest: | |||||||||||||||||||
75/125 Binney Street (sale of 60% noncontrolling interest)(2) | Cambridge/Greater Boston | 1Q19 | 388,270 | $ | 438,000 | $ | 1,880 | (2) | |||||||||||
Targeted Dispositions Guidance Midpoint | 312,000 | ||||||||||||||||||
2019 guidance midpoint | $ | 750,000 | |||||||||||||||||
(1) | In April 2018, our tenant exercised its option to purchase this Class B property at fair market value. The capitalization rates for this sale were 6.6% and 7.0% (cash basis). |
(2) | In February 2019, we executed a purchase and sale agreement to sell a 60% interest in 75/125 Binney Street, a Class A property in our Cambridge submarket, for a sales price of $438 million, or $1,880 per RSF, representing a 4.3% capitalization rate on 4Q18 net operating income (cash basis), annualized. The sale of a 60% ownership interest in this joint venture is expected to be accounted for as an equity transaction, with no gain to be recognized in earnings. Closing is expected to occur in 1Q19. Upon completion of the sale, we expect to retain control over the joint venture. We expect to reinvest the proceeds from this sale into our value-creation pipeline. |
Guidance | ![]() | |
December 31, 2018 | ||
(Dollars in millions, except per share amounts) | ||
Summary of Key Changes in Guidance | Guidance | Summary of Key Changes in Key Sources and Uses of Capital Guidance | Guidance Midpoint | ||||||||||||||||
As of 2/4/19 | As of 11/28/18 | As of 2/4/19 | As of 11/28/18 | ||||||||||||||||
EPS, FFO per share, and FFO per share, as adjusted | See updates below | Common equity | $ | 525 | $ | 625 | |||||||||||||
Capitalization of interest | $72 to $82 | $76 to $86 | Construction | $ | 1,300 | $ | 1,400 | ||||||||||||
Projected Earnings per Share and Funds From Operations per Share Attributable to Alexandria’s Common Stockholders – Diluted | |||||||||
As of 2/4/19 | As of 11/28/18 | ||||||||
Earnings per share (“EPS”)(1) | $1.95 to $2.15 | $2.05 to $2.25 | |||||||
Depreciation and amortization | 4.85 | 4.77 | |||||||
Allocation to unvested restricted stock awards | (0.03) | (0.03) | |||||||
Funds from operations per share(1) | $6.77 to $6.97 | $6.79 to $6.99 | |||||||
Loss on early extinguishment of debt in January 2019 | 0.06 | 0.06 | |||||||
Preferred stock redemption charge in January 2019 | 0.02 | — | |||||||
Funds from operations per share, as adjusted(2) | $6.85 to $7.05 | $6.85 to $7.05 | |||||||
Midpoint | $6.95 | $6.95 | |||||||
Key Assumptions | Low | High | |||||||
Occupancy percentage in North America as of December 31, 2019 | 97.7% | 98.3% | |||||||
Lease renewals and re-leasing of space: | |||||||||
Rental rate increases | 25.0% | 28.0% | |||||||
Rental rate increases (cash basis) | 11.0% | 14.0% | |||||||
Same property performance: | |||||||||
Net operating income increase | 1.0% | 3.0% | |||||||
Net operating income increase (cash basis) | 6.0% | 8.0% | |||||||
Straight-line rent revenue | $ | 95 | $ | 105 | (5) | ||||
General and administrative expenses | $ | 108 | $ | 113 | |||||
Capitalization of interest | $ | 72 | $ | 82 | |||||
Interest expense | $ | 172 | $ | 182 | |||||
2019 Guidance | |||
Key Credit Metrics | |||
Net debt to Adjusted EBITDA – 4Q19 annualized | Less than or equal to 5.3x | ||
Net debt and preferred stock to Adjusted EBITDA – 4Q19 annualized | Less than or equal to 5.4x | ||
Fixed-charge coverage ratio – 4Q19 annualized | Greater than 4.0x | ||
Value-creation pipeline as a percentage of gross real estate as of December 31, 2019 | 8% to 12% | ||
Key Sources and Uses of Capital | Range | Midpoint | |||||||||||
Sources of capital: | |||||||||||||
Net cash provided by operating activities after dividends | $ | 170 | $ | 210 | $ | 190 | |||||||
Incremental debt | 485 | 445 | 465 | ||||||||||
Real estate dispositions and partial interest sales: | |||||||||||||
Sale of partial interest in core class A property | 438 | 438 | 438 | (3) | |||||||||
Other | 262 | 362 | 312 | (3) | |||||||||
Common equity | 475 | 575 | 525 | ||||||||||
Total sources of capital | $ | 1,830 | $ | 2,030 | $ | 1,930 | |||||||
Uses of capital: | |||||||||||||
Construction | $ | 1,250 | $ | 1,350 | $ | 1,300 | |||||||
Acquisitions | 580 | 680 | 630 | (4) | |||||||||
Total uses of capital | $ | 1,830 | $ | 2,030 | $ | 1,930 | |||||||
Incremental debt (included above): | |||||||||||||
Issuance of unsecured senior notes payable | $ | 600 | $ | 700 | $ | 650 | |||||||
Repayments of secured notes payable | (120 | ) | (130 | ) | (125 | ) | |||||||
$2.2 billion unsecured senior line of credit/other | 5 | (125 | ) | (60 | ) | ||||||||
Incremental debt | $ | 485 | $ | 445 | $ | 465 | |||||||
(1) | Excludes future unrealized gains or losses after December 31, 2018 that are required to be recognized in earnings from changes in fair value of equity investments. |
(2) | Calculated in accordance with standards established by the Advisory Board of Governors of the National Association of Real Estate Investment Trusts (the “Nareit Board of Governors”). See definition of “Funds From Operations and Funds From Operations, As Adjusted, Attributable to Alexandria’s Common Stockholders” in the “Definitions and Reconciliations” section of our Supplemental Information for additional information. |
(3) | See “Dispositions and Sale of Partial Joint Venture Interest” in this Earnings Press Release for additional information. |
(4) | See “Acquisitions” in this Earnings Press Release for additional information. |
(5) | Approximately 45% of straight-line rent revenue represents initial free rent on recently delivered and expected 2019 deliveries of new Class A properties from our development and redevelopment pipeline. |
![]() | |
Earnings Call Information and About the Company | |
December 31, 2018 | |
Consolidated Statements of Operations | ![]() |
December 31, 2018 | |
(In thousands, except per share amounts) | |
Three Months Ended | Year Ended | |||||||||||||||||||||||||||
12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | 12/31/18 | 12/31/17 | ||||||||||||||||||||||
Revenues: | ||||||||||||||||||||||||||||
Rental | $ | 260,102 | $ | 255,496 | $ | 250,635 | $ | 244,485 | $ | 228,025 | $ | 1,010,718 | $ | 863,181 | ||||||||||||||
Tenant recoveries | 77,683 | 81,051 | 72,159 | 73,170 | 70,270 | 304,063 | 259,144 | |||||||||||||||||||||
Other income | 2,678 | 5,276 | 2,240 | 2,484 | 496 | 12,678 | 5,772 | |||||||||||||||||||||
Total revenues | 340,463 | 341,823 | 325,034 | 320,139 | 298,791 | 1,327,459 | 1,128,097 | |||||||||||||||||||||
Expenses: | ||||||||||||||||||||||||||||
Rental operations | 97,682 | 99,759 | 91,908 | 91,771 | 88,073 | 381,120 | 325,609 | |||||||||||||||||||||
General and administrative | 22,385 | 22,660 | 22,939 | 22,421 | 18,910 | 90,405 | 75,009 | |||||||||||||||||||||
Interest | 40,239 | 42,244 | 38,097 | 36,915 | 36,082 | 157,495 | 128,645 | |||||||||||||||||||||
Depreciation and amortization | 124,990 | 119,600 | 118,852 | 114,219 | 107,714 | 477,661 | 416,783 | |||||||||||||||||||||
Impairment of real estate | — | — | 6,311 | — | — | 6,311 | 203 | |||||||||||||||||||||
Loss on early extinguishment of debt | — | 1,122 | — | — | 2,781 | 1,122 | 3,451 | |||||||||||||||||||||
Total expenses | 285,296 | 285,385 | 278,107 | 265,326 | 253,560 | 1,114,114 | 949,700 | |||||||||||||||||||||
Equity in earnings of unconsolidated real estate joint ventures | 1,029 | 40,718 | (1) | 1,090 | 1,144 | 376 | 43,981 | 15,426 | ||||||||||||||||||||
Investment (loss) income(2) | (83,531 | ) | (2) | 122,203 | 12,530 | 85,561 | — | 136,763 | (2) | — | ||||||||||||||||||
Gain on sales of real estate – rental properties | 8,704 | — | — | — | — | 8,704 | 270 | |||||||||||||||||||||
Gain on sales of real estate – land parcels | — | — | — | — | — | — | 111 | |||||||||||||||||||||
Net (loss) income | (18,631 | ) | 219,359 | 60,547 | 141,518 | 45,607 | 402,793 | 194,204 | ||||||||||||||||||||
Net income attributable to noncontrolling interests | (6,053 | ) | (5,723 | ) | (5,817 | ) | (5,888 | ) | (6,219 | ) | (23,481 | ) | (25,111 | ) | ||||||||||||||
Net (loss) income attributable to Alexandria Real Estate Equities, Inc.’s stockholders | (24,684 | ) | 213,636 | 54,730 | 135,630 | 39,388 | 379,312 | 169,093 | ||||||||||||||||||||
Dividends on preferred stock | (1,155 | ) | (1,301 | ) | (1,302 | ) | (1,302 | ) | (1,302 | ) | (5,060 | ) | (7,666 | ) | ||||||||||||||
Preferred stock redemption charge | (4,240 | ) | — | — | — | — | (4,240 | ) | (11,279 | ) | ||||||||||||||||||
Net income attributable to unvested restricted stock awards | (1,661 | ) | (3,395 | ) | (1,412 | ) | (1,941 | ) | (1,255 | ) | (6,029 | ) | (4,753 | ) | ||||||||||||||
Net (loss) income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders | $ | (31,740 | ) | $ | 208,940 | $ | 52,016 | $ | 132,387 | $ | 36,831 | $ | 363,983 | $ | 145,395 | |||||||||||||
Net (loss) income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders: | ||||||||||||||||||||||||||||
Basic | $ | (0.30 | ) | $ | 2.01 | $ | 0.51 | $ | 1.33 | $ | 0.39 | $ | 3.53 | $ | 1.59 | |||||||||||||
Diluted | $ | (0.30 | ) | $ | 1.99 | $ | 0.51 | $ | 1.32 | $ | 0.38 | $ | 3.52 | $ | 1.58 | |||||||||||||
Weighted-average shares of common stock outstanding: | ||||||||||||||||||||||||||||
Basic | 106,033 | 104,179 | 101,881 | 99,855 | 95,138 | 103,010 | 91,546 | |||||||||||||||||||||
Diluted | 106,033 | 105,385 | 102,236 | 100,125 | 95,914 | 103,321 | 92,063 | |||||||||||||||||||||
Dividends declared per share of common stock | $ | 0.97 | $ | 0.93 | $ | 0.93 | $ | 0.90 | $ | 0.90 | $ | 3.73 | $ | 3.45 | ||||||||||||||
(1) | Includes $35.7 million related to the gain on sale of our remaining 27.5% ownership interest in the unconsolidated real estate joint venture in 360 Longwood Avenue. See “Joint Venture Financial Information” in our Supplemental Information for additional information. |
(2) | See “Investments” in our Supplemental Information for additional information. |
Consolidated Balance Sheets | ![]() |
December 31, 2018 | |
(In thousands) | |
12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | ||||||||||||||||
Assets | ||||||||||||||||||||
Investments in real estate | $ | 11,913,693 | $ | 11,587,312 | $ | 11,190,771 | $ | 10,671,227 | $ | 10,298,019 | ||||||||||
Investments in unconsolidated real estate joint ventures | 237,507 | 197,970 | 192,972 | 169,865 | 110,618 | |||||||||||||||
Cash and cash equivalents | 234,181 | 204,181 | 287,029 | 221,645 | 254,381 | |||||||||||||||
Restricted cash | 37,949 | 29,699 | 34,812 | 37,337 | 22,805 | |||||||||||||||
Tenant receivables | 9,798 | 11,041 | 8,704 | 11,258 | 10,262 | |||||||||||||||
Deferred rent | 530,237 | 511,680 | 490,428 | 467,112 | 434,731 | |||||||||||||||
Deferred leasing costs | 239,070 | 238,295 | 232,964 | 226,803 | 221,430 | |||||||||||||||
Investments | 892,264 | 957,356 | 790,753 | 724,310 | 523,254 | |||||||||||||||
Other assets | 370,257 | 368,032 | 333,757 | 291,639 | 228,453 | |||||||||||||||
Total assets | $ | 14,464,956 | $ | 14,105,566 | $ | 13,562,190 | $ | 12,821,196 | $ | 12,103,953 | ||||||||||
Liabilities, Noncontrolling Interests, and Equity | ||||||||||||||||||||
Secured notes payable | $ | 630,547 | $ | 632,792 | $ | 776,260 | $ | 775,689 | $ | 771,061 | ||||||||||
Unsecured senior notes payable | 4,292,293 | 4,290,906 | 4,289,521 | 3,396,912 | 3,395,804 | |||||||||||||||
Unsecured senior line of credit | 208,000 | 413,000 | — | 490,000 | 50,000 | |||||||||||||||
Unsecured senior bank term loans | 347,415 | 347,306 | 548,324 | 548,197 | 547,942 | |||||||||||||||
Accounts payable, accrued expenses, and tenant security deposits | 981,707 | 907,094 | 849,274 | 783,986 | 763,832 | |||||||||||||||
Dividends payable | 110,280 | 101,084 | 98,676 | 93,065 | 92,145 | |||||||||||||||
Total liabilities | 6,570,242 | 6,692,182 | 6,562,055 | 6,087,849 | 5,620,784 | |||||||||||||||
Commitments and contingencies | ||||||||||||||||||||
Redeemable noncontrolling interests | 10,786 | 10,771 | 10,861 | 10,212 | 11,509 | |||||||||||||||
Alexandria Real Estate Equities, Inc.’s stockholders’ equity: | ||||||||||||||||||||
7.00% Series D cumulative convertible preferred stock | 64,336 | 74,386 | 74,386 | 74,386 | 74,386 | |||||||||||||||
Common stock | 1,110 | 1,058 | 1,033 | 1,007 | 998 | |||||||||||||||
Additional paid-in capital | 7,286,954 | 6,801,150 | 6,387,527 | 6,117,976 | 5,824,258 | |||||||||||||||
Accumulated other comprehensive (loss) income | (10,435 | ) | (3,811 | ) | (2,485 | ) | 1,228 | 50,024 | ||||||||||||
Alexandria Real Estate Equities, Inc.’s stockholders’ equity | 7,341,965 | 6,872,783 | 6,460,461 | 6,194,597 | 5,949,666 | |||||||||||||||
Noncontrolling interests | 541,963 | 529,830 | 528,813 | 528,538 | 521,994 | |||||||||||||||
Total equity | 7,883,928 | 7,402,613 | 6,989,274 | 6,723,135 | 6,471,660 | |||||||||||||||
Total liabilities, noncontrolling interests, and equity | $ | 14,464,956 | $ | 14,105,566 | $ | 13,562,190 | $ | 12,821,196 | $ | 12,103,953 | ||||||||||
Funds From Operations and Funds From Operations per Share | ![]() |
December 31, 2018 | |
(In thousands) | |
Three Months Ended | Year Ended | |||||||||||||||||||||||||||
12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | 12/31/18 | 12/31/17 | ||||||||||||||||||||||
Net (loss) income attributable to Alexandria’s common stockholders – basic | $ | (31,740 | ) | $ | 208,940 | $ | 52,016 | $ | 132,387 | $ | 36,831 | $ | 363,983 | $ | 145,395 | |||||||||||||
Assumed conversion of 7.00% Series D cumulative convertible preferred stock(1) | — | 1,301 | — | — | — | — | — | |||||||||||||||||||||
Net (loss) income attributable to Alexandria’s common stockholders – diluted | (31,740 | ) | 210,241 | 52,016 | 132,387 | 36,831 | 363,983 | 145,395 | ||||||||||||||||||||
Depreciation and amortization | 124,990 | 119,600 | 118,852 | 114,219 | 107,714 | 477,661 | 416,783 | |||||||||||||||||||||
Noncontrolling share of depreciation and amortization from consolidated real estate JVs | (4,252 | ) | (4,044 | ) | (3,914 | ) | (3,867 | ) | (3,777 | ) | (16,077 | ) | (14,762 | ) | ||||||||||||||
Our share of depreciation and amortization from unconsolidated real estate JVs | 719 | 1,011 | 807 | 644 | 432 | 3,181 | 1,551 | |||||||||||||||||||||
Gain on sales of real estate – rental properties | (8,704 | ) | — | — | — | — | (8,704 | ) | (270 | ) | ||||||||||||||||||
Our share of gain on sales of real estate from unconsolidated real estate JVs(2) | — | (35,678 | ) | — | — | — | (35,678 | ) | (14,106 | ) | ||||||||||||||||||
Gain on sales of real estate – land parcels | — | — | — | — | — | — | (111 | ) | ||||||||||||||||||||
Impairment of real estate – rental properties | — | — | — | — | — | — | 203 | |||||||||||||||||||||
Assumed conversion of 7.00% Series D cumulative convertible preferred stock(1) | — | — | — | 1,302 | — | 5,060 | — | |||||||||||||||||||||
Allocation to unvested restricted stock awards | — | (1,312 | ) | (1,042 | ) | (1,548 | ) | (734 | ) | (5,961 | ) | (2,920 | ) | |||||||||||||||
Funds from operations attributable to Alexandria’s common stockholders – diluted(3) | 81,013 | 289,818 | 166,719 | 243,137 | 140,466 | 783,465 | 531,763 | |||||||||||||||||||||
Unrealized losses (gains) on non-real estate investments | 94,850 | (117,188 | ) | (5,067 | ) | (72,229 | ) | — | (99,634 | ) | — | |||||||||||||||||
Realized gains on non-real estate investments | (6,428 | ) | (4) | — | — | (8,252 | ) | — | (14,680 | ) | — | |||||||||||||||||
Impairment of real estate – land parcels | — | — | 6,311 | — | — | 6,311 | — | |||||||||||||||||||||
Impairment of non-real estate investments | 5,483 | (4) | — | — | — | 3,805 | 5,483 | 8,296 | ||||||||||||||||||||
Loss on early extinguishment of debt | — | 1,122 | — | — | 2,781 | 1,122 | 3,451 | |||||||||||||||||||||
Our share of gain on early extinguishment of debt from unconsolidated real estate JVs(2) | — | (761 | ) | — | — | — | (761 | ) | — | |||||||||||||||||||
Preferred stock redemption charge | 4,240 | — | — | — | — | 4,240 | 11,279 | |||||||||||||||||||||
Removal of assumed conversion of 7.00% Series D cumulative convertible preferred stock(1) | — | (1,301 | ) | — | (1,302 | ) | — | (5,060 | ) | — | ||||||||||||||||||
Allocation to unvested restricted stock awards | (1,138 | ) | 1,889 | (18 | ) | 1,125 | (94 | ) | 1,517 | (321 | ) | |||||||||||||||||
Funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted | $ | 178,020 | $ | 173,579 | $ | 167,945 | $ | 162,479 | $ | 146,958 | $ | 682,003 | $ | 554,468 | ||||||||||||||
(1) | See definition of “Weighted-Average Shares of Common Stock Outstanding – Diluted” in the “Definitions and Reconciliations” section of our Supplemental Information for additional information regarding our 7.00% Series D cumulative convertible preferred stock. |
(2) | Classified in equity in earnings (losses) of unconsolidated real estate joint ventures in our consolidated statements of operations. |
(3) | Calculated in accordance with standards established by the Advisory Board of Governors of the National Association of Real Estate Investment Trusts (the “Nareit Board of Governors”). See definition of “Funds From Operations and Funds From Operations, As Adjusted, Attributable to Alexandria’s Common Stockholders” in the “Definitions and Reconciliations” section of our Supplemental Information for additional information. |
(4) | Realized gain of $6.4 million relates to one publicly traded non-real estate investment in a biopharmaceutical entity and impairments of $5.5 million primarily relates to one privately held non-real estate investment. Both line items are classified in investment (loss) income in our consolidated statements of operations. Excluding these gains and impairments, our realized gains on non-real estate investments were $10.4 million for the three months ended December 31, 2018. |
Funds From Operations and Funds From Operations per Share (continued) | ![]() |
December 31, 2018 | |
(In thousands, except per share amounts) | |
Three Months Ended | Year Ended | |||||||||||||||||||||||||||
12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | 12/31/18 | 12/31/17 | ||||||||||||||||||||||
Net (loss) income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted | $ | (0.30 | ) | $ | 1.99 | $ | 0.51 | $ | 1.32 | $ | 0.38 | $ | 3.52 | $ | 1.58 | |||||||||||||
Depreciation and amortization | 1.14 | 1.11 | 1.13 | 1.08 | 1.08 | 4.50 | 4.35 | |||||||||||||||||||||
Gain on sale of real estate – rental properties | (0.08 | ) | — | — | — | — | (0.08 | ) | — | |||||||||||||||||||
Our share of gain on sales of real estate from unconsolidated real estate JVs | — | (0.34 | ) | — | — | — | (0.35 | ) | (0.15 | ) | ||||||||||||||||||
Assumed conversion of 7.00% Series D cumulative convertible preferred stock(1) | — | — | — | 0.01 | — | — | (2) | — | ||||||||||||||||||||
Allocation to unvested restricted stock awards | — | (0.01 | ) | (0.01 | ) | — | — | (0.06 | ) | — | ||||||||||||||||||
Funds from operations per share attributable to Alexandria’s common stockholders – diluted(3) | 0.76 | 2.75 | 1.63 | 2.41 | 1.46 | 7.53 | 5.78 | |||||||||||||||||||||
Unrealized losses (gains) on non-real estate investments | 0.89 | (1.11 | ) | (0.05 | ) | (0.70 | ) | — | (0.96 | ) | — | |||||||||||||||||
Realized gains on non-real estate investments | (0.06 | ) | (4) | — | — | (0.08 | ) | — | (0.14 | ) | — | |||||||||||||||||
Impairment of real estate – land parcels | — | — | 0.06 | — | — | 0.06 | — | |||||||||||||||||||||
Impairment of non-real estate investments | 0.05 | (4) | — | — | — | 0.04 | 0.05 | 0.09 | ||||||||||||||||||||
Loss on early extinguishment of debt | — | 0.01 | — | — | 0.03 | 0.01 | 0.03 | |||||||||||||||||||||
Our share of gain on early extinguishment of debt from unconsolidated real estate JVs | — | (0.01 | ) | — | — | — | (0.01 | ) | — | |||||||||||||||||||
Preferred stock redemption charge | 0.04 | — | — | — | — | 0.04 | 0.12 | |||||||||||||||||||||
Removal of assumed conversion of 7.00% Series D cumulative convertible preferred stock(1) | — | — | — | (0.01 | ) | — | — | — | ||||||||||||||||||||
Allocation to unvested restricted stock awards | — | 0.02 | — | — | — | 0.02 | — | |||||||||||||||||||||
Funds from operations per share attributable to Alexandria’s common stockholders – diluted, as adjusted | $ | 1.68 | $ | 1.66 | $ | 1.64 | $ | 1.62 | $ | 1.53 | $ | 6.60 | $ | 6.02 | ||||||||||||||
Weighted-average shares of common stock outstanding(1) for calculations of: | ||||||||||||||||||||||||||||
Earnings per share – diluted | 106,033 | 105,385 | 102,236 | 100,125 | 95,914 | 103,321 | 92,063 | |||||||||||||||||||||
Funds from operations – diluted, per share | 106,244 | 105,385 | 102,236 | 100,866 | 95,914 | 104,048 | 92,063 | |||||||||||||||||||||
Funds from operations – diluted, as adjusted, per share | 106,244 | 104,641 | 102,236 | 100,125 | 95,914 | 103,321 | 92,063 | |||||||||||||||||||||
(1) | See footnote 1 on the previous page for additional information. |
(2) | The assumed conversion of our 7.00% Series D cumulative convertible preferred stock required the addition of $5.1 million of dividends on preferred stock to the numerator, and the addition of 727 thousand shares to the denominator while calculating funds from operations per share attributable to Alexandria’s common stockholders – diluted. These amounts had approximately no dilutive impact on a per share basis. |
(3) | Calculated in accordance with standards established by the Nareit Board of Governors. See definition of “Funds From Operations and Funds From Operations, As Adjusted, Attributable to Alexandria’s Common Stockholders” in the “Definitions and Reconciliations” section of our Supplemental Information for additional information. |
(4) | See footnote 4 on the previous page for additional information. |
![]() | |
Company Profile | |
December 31, 2018 | |
EXECUTIVE MANAGEMENT TEAM |
Joel S. Marcus |
Executive Chairman & Founder |
Stephen A. Richardson |
Co-Chief Executive Officer |
Peter M. Moglia |
Co-Chief Executive Officer & Co-Chief Investment Officer |
Dean A. Shigenaga |
Co-President & Chief Financial Officer |
Thomas J. Andrews |
Co-President & Regional Market Director – Greater Boston |
Daniel J. Ryan |
Co-Chief Investment Officer & Regional Market Director – San Diego |
Jennifer J. Banks |
Co-Chief Operating Officer, General Counsel & Corporate Secretary |
Lawrence J. Diamond |
Co-Chief Operating Officer & Regional Market Director – Maryland |
Vincent R. Ciruzzi |
Chief Development Officer |
John H. Cunningham |
Executive Vice President & Regional Market Director – New York City |
![]() | |
Investor Information | |
December 31, 2018 | |
Corporate Headquarters | New York Stock Exchange Trading Symbols | Information Requests | |||
385 East Colorado Boulevard, Suite 299 | Common stock: ARE | Phone: | (626) 578-0777 | ||
Pasadena, California 91101 | 7.00% Series D preferred stock: ARE PRD | Email: | |||
Web: | www.are.com | ||||
Equity Research Coverage |
Alexandria is currently covered by the following research analysts. This list may be incomplete and is subject to change as firms initiate or discontinue coverage of our company. Please note that any opinions, estimates, or forecasts regarding our historical or predicted performance made by these analysts are theirs alone and do not represent opinions, estimates, or forecasts of Alexandria or our management. Alexandria does not by our reference or distribution of the information below imply our endorsement of or concurrence with any opinions, estimates, or forecasts of these analysts. Interested persons may obtain copies of analysts’ reports on their own as we do not distribute these reports. Several of these firms may, from time to time, own our stock and/or hold other long or short positions in our stock and may provide compensated services to us. |
Bank of America Merrill Lynch | Citigroup Global Markets Inc. | J.P. Morgan Securities LLC | RBC Capital Markets | |||
Jamie Feldman / Jeffrey Spector | Michael Bilerman / Emmanuel Korchman | Anthony Paolone / Patrice Chen | Michael Carroll / Jason Idoine | |||
(646) 855-5808 / (646) 855-1363 | (212) 816-1383 / (212) 816-1382 | (212) 622-6682 / (212) 622-1893 | (440) 715-2649 / (440) 715-2651 | |||
Barclays Capital Inc. | Evercore ISI | Mitsubishi UFJ Securities (USA), Inc. | Robert W. Baird & Co. Incorporated | |||
Ross Smotrich / Trevor Young | Sheila McGrath / Wendy Ma | Karin Ford / Ryan Cybart | David Rodgers | |||
(212) 526-2306 / (212) 526-3098 | (212) 497-0882 / (212) 497-0870 | (212) 405-7249 / (212) 405-6591 | (216) 737-7341 | |||
BTIG, LLC | Green Street Advisors, Inc. | Mizuho Securities USA Inc. | UBS Securities LLC | |||
Tom Catherwood / James Sullivan | Daniel Ismail / Chris Darling | Haendel St. Juste / Zachary Silverberg | Frank Lee | |||
(212) 738-6140 / (212) 738-6139 | (949) 640-8780 / (949) 640-8780 | (212) 209-9300 / (212) 205-7855 | (415) 352-5679 | |||
CFRA | JMP Securities – JMP Group, Inc. | |||||
Kenneth Leon | Peter Martin | |||||
(212) 438-4638 | (415) 835-8904 | |||||
Fixed Income Coverage | Rating Agencies | |||||
J.P. Morgan Securities LLC | Wells Fargo & Company | Moody’s Investors Service | S&P Global Ratings | |||
Mark Streeter / Ian Snyder | Thierry Perrein / Kevin McClure | (212) 553-0376 | Fernanda Hernandez / Michael Souers | |||
(212) 834-5086 / (212) 834-3798 | (704) 410-3262 / (704) 410-3252 | (212) 438-1347 / (212) 438-2508 | ||||
![]() | |
Sustainability | |
December 31, 2018 | |

(1) | For the years ended December 31, 2016 and 2017. We expect to disclose data for the year ended December 31, 2018, in 2019. |
(2) | Upon completion of 15 projects in process targeting LEED certification. |
(3) | Upon completion of three projects in process targeting WELL certification. |
(4) | Upon completion of 12 projects in process targeting Fitwel certification. |
![]() | |
High-Quality, Diverse, and Innovative Tenants | |
December 31, 2018 | |
Investment-Grade or Publicly Traded Large Cap Tenants | Tenant Mix | |||
![]() | ||||
52% | ||||
of ARE’s Total | ||||
Annual Rental Revenue(1) | ||||
A REIT Industry-Leading Tenant Roster | Percentage of ARE’s Annual Rental Revenue(1) | |||
(1) | Represents annual rental revenue in effect as of December 31, 2018. |
(2) | Our annual rental revenue from technology tenants consists of: |
• | 39% from investment-grade credit rated or publicly traded large cap tenants |
• | 49% from Uber Technologies, Inc., Stripe, Inc., and Pinterest, Inc. |
• | 12% from all other technology tenants |
![]() | |
Class A Properties in AAA Locations | |
December 31, 2018 | |
Class A Properties in AAA Locations | AAA Locations | |||
![]() | ||||
77% | ||||
of ARE’s | ||||
Annual Rental Revenue(1) | ||||
Percentage of ARE’s Annual Rental Revenue(1) | ||||
(1) | Represents annual rental revenue in effect as of December 31, 2018. |
![]() | |
Occupancy | |
December 31, 2018 | |
Solid Historical Occupancy(1) | Occupancy Across Key Locations | |||
![]() | ||||
96% | ||||
Over 10 Years | ||||
(1) | Average occupancy of operating properties in North America as of each December 31 for the last 10 years. |
Financial and Asset Base Highlights | ![]() |
December 31, 2018 | |
(Dollars in thousands, except per share amounts) | |
Three Months Ended (unless stated otherwise) | ||||||||||||||||||||
12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | ||||||||||||||||
Selected financial data from consolidated financial statements and related information | ||||||||||||||||||||
Operating margin | 71% | 71% | 72% | 71% | 71% | |||||||||||||||
Adjusted EBITDA margin | 69% | 69% | 69% | 69% | 68% | |||||||||||||||
Adjusted EBITDA – quarter annualized | $ | 968,888 | $ | 957,008 | $ | 911,284 | $ | 914,444 | $ | 817,392 | ||||||||||
Adjusted EBITDA – trailing 12 months | $ | 937,906 | $ | 900,032 | $ | 854,237 | $ | 815,178 | $ | 767,508 | ||||||||||
Net debt at end of period | $ | 5,237,538 | $ | 5,483,132 | $ | 5,326,039 | $ | 4,979,254 | $ | 4,516,672 | ||||||||||
Net debt to Adjusted EBITDA – quarter annualized | 5.4x | 5.7x | 5.8x | 5.4x | 5.5x | |||||||||||||||
Net debt to Adjusted EBITDA – trailing 12 months | 5.6x | 6.1x | 6.2x | 6.1x | 5.9x | |||||||||||||||
Net debt and preferred stock to Adjusted EBITDA – quarter annualized | 5.5x | 5.8x | 5.9x | 5.5x | 5.6x | |||||||||||||||
Net debt and preferred stock to Adjusted EBITDA – trailing 12 months | 5.7x | 6.2x | 6.3x | 6.2x | 6.0x | |||||||||||||||
Fixed-charge coverage ratio – quarter annualized | 4.1x | 4.1x | 4.3x | 4.6x | 4.2x | |||||||||||||||
Fixed-charge coverage ratio – trailing 12 months | 4.2x | 4.3x | 4.3x | 4.3x | 4.1x | |||||||||||||||
Unencumbered net operating income as a percentage of total net operating income | 88% | 88% | 88% | 87% | 86% | |||||||||||||||
Closing stock price at end of period | $ | 115.24 | $ | 125.79 | $ | 126.17 | $ | 124.89 | $ | 130.59 | ||||||||||
Common shares outstanding (in thousands) at end of period | 111,012 | 105,804 | 103,346 | 100,696 | 99,784 | |||||||||||||||
Total equity capitalization at end of period | $ | 12,879,366 | $ | 13,412,222 | $ | 13,142,725 | $ | 12,682,876 | $ | 13,140,843 | ||||||||||
Total market capitalization at end of period | $ | 18,357,621 | $ | 19,096,226 | $ | 18,756,830 | $ | 17,893,674 | $ | 17,905,650 | ||||||||||
Dividend per share – quarter/annualized | $0.97/$3.88 | $0.93/$3.72 | $0.93/$3.72 | $0.90/$3.60 | $0.90/$3.60 | |||||||||||||||
Dividend payout ratio for the quarter | 60% | 57% | 57% | 56% | 61% | |||||||||||||||
Dividend yield – annualized | 3.4% | 3.0% | 2.9% | 2.9% | 2.8% | |||||||||||||||
General and administrative expenses as a percentage of net operating income – trailing 12 months | 9.6% | 9.5% | 9.4% | 9.3% | 9.3% | |||||||||||||||
Capitalized interest | $ | 19,902 | $ | 17,431 | $ | 15,527 | $ | 13,360 | $ | 12,897 | ||||||||||
Weighted-average interest rate for capitalization of interest during the period | 4.01% | 4.06% | 3.92% | 3.91% | 3.89% | |||||||||||||||
Financial and Asset Base Highlights (continued) | ![]() |
December 31, 2018 | |
(Dollars in thousands, except annual rental revenue per occupied RSF amounts) | |
Three Months Ended (unless stated otherwise) | ||||||||||||||||||||
12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | ||||||||||||||||
Amounts included in funds from operations and non-revenue-enhancing capital expenditures | ||||||||||||||||||||
Straight-line rent revenue | $ | 17,923 | $ | 20,070 | $ | 23,259 | $ | 32,631 | $ | 33,281 | ||||||||||
Amortization of acquired below-market leases | $ | 5,350 | $ | 5,220 | $ | 5,198 | $ | 6,170 | $ | 4,147 | ||||||||||
Straight-line rent expense on ground leases | $ | 272 | $ | 272 | $ | 252 | $ | 240 | $ | 205 | ||||||||||
Stock compensation expense | $ | 9,810 | $ | 9,986 | $ | 7,975 | $ | 7,248 | $ | 6,961 | ||||||||||
Amortization of loan fees | $ | 2,401 | $ | 2,734 | $ | 2,593 | $ | 2,543 | $ | 2,571 | ||||||||||
Amortization of debt premiums | $ | 611 | $ | 614 | $ | 606 | $ | 575 | $ | 639 | ||||||||||
Non-revenue-enhancing capital expenditures: | ||||||||||||||||||||
Building improvements | $ | 3,256 | $ | 3,032 | $ | 2,827 | $ | 2,625 | $ | 2,469 | ||||||||||
Tenant improvements and leasing commissions | $ | 11,758 | $ | 17,748 | $ | 10,686 | $ | 2,836 | $ | 9,578 | ||||||||||
Operating statistics and related information (at end of period) | ||||||||||||||||||||
Number of properties – North America | 237 | 235 | 234 | 222 | 213 | |||||||||||||||
RSF – North America (including development and redevelopment projects under construction) | 24,587,438 | 24,196,505 | 24,007,981 | 23,066,089 | 21,981,133 | |||||||||||||||
Total square feet – North America | 33,097,210 | 32,186,813 | 31,976,194 | 30,240,017 | 29,563,221 | |||||||||||||||
Annual rental revenue per occupied RSF – North America | $ | 48.42 | $ | 48.36 | $ | 48.22 | $ | 48.09 | $ | 48.01 | ||||||||||
Occupancy of operating properties – North America | 97.3% | 97.3% | 97.1% | 96.6% | 96.8% | |||||||||||||||
Occupancy of operating and redevelopment properties – North America | 95.1% | 94.6% | 95.0% | 94.3% | 94.7% | |||||||||||||||
Weighted average remaining lease term (in years) | 8.6 | 8.6 | 8.6 | 8.7 | 8.9 | |||||||||||||||
Total leasing activity – RSF | 1,558,064 | 696,468 | 985,996 | 1,481,164 | 1,379,699 | |||||||||||||||
Lease renewals and re-leasing of space – change in average new rental rates over expiring rates: | ||||||||||||||||||||
Rental rate increases | 17.4% | 35.4% | 24.0% | 16.3% | 24.8% | |||||||||||||||
Rental rate increases (cash basis) | 11.4% | 16.9% | 12.8% | 19.0% | 10.4% | |||||||||||||||
RSF (included in total leasing activity above) | 650,540 | 475,863 | 727,265 | 234,548 | 593,622 | |||||||||||||||
Same property – percentage change over comparable quarter from prior year: | ||||||||||||||||||||
Net operating income increase | 3.8% | 3.4% | 4.1% | 4.0% | 4.5% | |||||||||||||||
Net operating income increase (cash basis) | 7.6% | 8.9% | 6.3% | 14.6% | 12.5% | |||||||||||||||
![]() | |
Key Operating Metrics | |
December 31, 2018 | |
Favorable Lease Structure(1) | Same Property Net Operating Income Growth | |||||||||
![]() | ![]() | |||||||||
Stable cash flows | ||||||||||
Percentage of triple net leases | 97% | |||||||||
Increasing cash flows | ||||||||||
Percentage of leases containing annual rent escalations | 95% | |||||||||
Lower capex burden | ||||||||||
Percentage of leases providing for the recapture of capital expenditures | 96% | |||||||||
Margins(2) | Rental Rate Growth: Renewed/Re-Leased Space | |||||||||
![]() | ![]() | |||||||||
Operating | Adjusted EBITDA | |||||||||
71% | 69% | |||||||||
(1) | Percentages calculated based on RSF as of December 31, 2018. |
(2) | Represents percentages for the three months ended December 31, 2018. |
Same Property Performance | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Same Property Financial Data | 4Q18 | 2018 | Same Property Statistical Data | 4Q18 | 2018 | |||||
Percentage change over comparable period from prior year: | Number of same properties | 188 | 185 | |||||||
Net operating income increase | 3.8% | 3.7% | Rentable square feet | 17,641,401 | 17,221,297 | |||||
Net operating income increase (cash basis) | 7.6% | 9.2% | Occupancy – current-period average | 97.0% | 96.6% | |||||
Operating margin | 71% | 71% | Occupancy – same-period prior-year average | 96.3% | 96.1% | |||||
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||||||||||||
2018 | 2017 | $ Change | % Change | 2018 | 2017 | $ Change | % Change | ||||||||||||||||||||||||
Same properties | $ | 212,897 | $ | 204,729 | $ | 8,168 | 4.0 | % | $ | 818,706 | $ | 788,169 | $ | 30,537 | 3.9 | % | |||||||||||||||
Non-same properties | 47,205 | 23,296 | 23,909 | 102.6 | 192,012 | 75,012 | 117,000 | 156.0 | |||||||||||||||||||||||
Total rental | 260,102 | 228,025 | 32,077 | 14.1 | 1,010,718 | 863,181 | 147,537 | 17.1 | |||||||||||||||||||||||
Same properties | 67,344 | 65,979 | 1,365 | 2.1 | 266,378 | 247,502 | 18,876 | 7.6 | |||||||||||||||||||||||
Non-same properties | 10,339 | 4,291 | 6,048 | 140.9 | 37,685 | 11,642 | 26,043 | 223.7 | |||||||||||||||||||||||
Total tenant recoveries | 77,683 | 70,270 | 7,413 | 10.5 | 304,063 | 259,144 | 44,919 | 17.3 | |||||||||||||||||||||||
Same properties | 115 | 59 | 56 | 94.9 | 314 | 201 | 113 | 56.2 | |||||||||||||||||||||||
Non-same properties | 2,563 | 437 | 2,126 | 486.5 | 12,364 | 5,571 | 6,793 | 121.9 | |||||||||||||||||||||||
Total other income | 2,678 | 496 | 2,182 | 439.9 | 12,678 | 5,772 | 6,906 | 119.6 | |||||||||||||||||||||||
Same properties | 280,356 | 270,767 | 9,589 | 3.5 | 1,085,398 | 1,035,872 | 49,526 | 4.8 | |||||||||||||||||||||||
Non-same properties | 60,107 | 28,024 | 32,083 | 114.5 | 242,061 | 92,225 | 149,836 | 162.5 | |||||||||||||||||||||||
Total revenues | 340,463 | 298,791 | 41,672 | 13.9 | 1,327,459 | 1,128,097 | 199,362 | 17.7 | |||||||||||||||||||||||
Same properties | 80,289 | 77,954 | 2,335 | 3.0 | 314,121 | 292,178 | 21,943 | 7.5 | |||||||||||||||||||||||
Non-same properties | 17,393 | 10,119 | 7,274 | 71.9 | 66,999 | 33,431 | 33,568 | 100.4 | |||||||||||||||||||||||
Total rental operations | 97,682 | 88,073 | 9,609 | 10.9 | 381,120 | 325,609 | 55,511 | 17.0 | |||||||||||||||||||||||
Same properties | 200,067 | 192,813 | 7,254 | 3.8 | 771,277 | 743,694 | 27,583 | 3.7 | |||||||||||||||||||||||
Non-same properties | 42,714 | 17,905 | 24,809 | 138.6 | 175,062 | 58,794 | 116,268 | 197.8 | |||||||||||||||||||||||
Net operating income | $ | 242,781 | $ | 210,718 | $ | 32,063 | 15.2 | % | $ | 946,339 | $ | 802,488 | $ | 143,851 | 17.9 | % | |||||||||||||||
Net operating income – same properties | $ | 200,067 | $ | 192,813 | $ | 7,254 | 3.8 | % | $ | 771,277 | $ | 743,694 | $ | 27,583 | 3.7 | % | |||||||||||||||
Straight-line rent revenue | (10,614 | ) | (15,671 | ) | 5,057 | (32.3 | ) | (48,061 | ) | (77,580 | ) | 29,519 | (38.0 | ) | |||||||||||||||||
Amortization of acquired below-market leases | (3,210 | ) | (3,982 | ) | 772 | (19.4 | ) | (9,548 | ) | (12,842 | ) | 3,294 | (25.7 | ) | |||||||||||||||||
Net operating income – same properties (cash basis) | $ | 186,243 | $ | 173,160 | $ | 13,083 | 7.6 | % | $ | 713,668 | $ | 653,272 | $ | 60,396 | 9.2 | % | |||||||||||||||
Leasing Activity | ![]() |
December 31, 2018 | |
(Dollars per RSF) | |
Three Months Ended | Year Ended | Year Ended | ||||||||||||||||||||||||||||||||||
December 31, 2018 | December 31, 2018 | December 31, 2017 | ||||||||||||||||||||||||||||||||||
Including Straight-Line Rent | Cash Basis | Including Straight-Line Rent | Cash Basis | Including Straight-Line Rent | Cash Basis | |||||||||||||||||||||||||||||||
Leasing activity: | ||||||||||||||||||||||||||||||||||||
Renewed/re-leased space(1) | ||||||||||||||||||||||||||||||||||||
Rental rate changes | 17.4% | (2) | 11.4% | 24.1% | 14.1% | 25.1% | 12.7% | |||||||||||||||||||||||||||||
New rates | $52.66 | $51.35 | $55.05 | $52.79 | $51.05 | $47.99 | ||||||||||||||||||||||||||||||
Expiring rates | $44.85 | $46.08 | $44.35 | $46.25 | $40.80 | $42.60 | ||||||||||||||||||||||||||||||
Rentable square footage | 650,540 | 2,088,216 | 2,525,099 | |||||||||||||||||||||||||||||||||
Tenant improvements/leasing commissions | $17.01 | $20.61 | $18.74 | |||||||||||||||||||||||||||||||||
Weighted-average lease term | 6.7 years | 6.1 years | 6.2 years | |||||||||||||||||||||||||||||||||
Developed/redeveloped/previously vacant space leased | ||||||||||||||||||||||||||||||||||||
New rates | $43.15 | $34.45 | $58.45 | $48.73 | $47.56 | $42.93 | ||||||||||||||||||||||||||||||
Rentable square footage | 907,524 | 2,633,476 | 2,044,083 | |||||||||||||||||||||||||||||||||
Tenant improvements/leasing commissions | $9.79 | $12.57 | $9.83 | |||||||||||||||||||||||||||||||||
Weighted-average lease term | 8.9 years | 11.5 years | 10.1 years | |||||||||||||||||||||||||||||||||
Leasing activity summary (totals): | ||||||||||||||||||||||||||||||||||||
New rates | $47.12 | $41.51 | $56.94 | $50.52 | $49.49 | $45.72 | ||||||||||||||||||||||||||||||
Rentable square footage | 1,558,064 | 4,721,692 | (3) | 4,569,182 | ||||||||||||||||||||||||||||||||
Tenant improvements/leasing commissions | $12.80 | $16.13 | $14.75 | |||||||||||||||||||||||||||||||||
Weighted-average lease term | 8.0 years | 9.1 years | 7.9 years | |||||||||||||||||||||||||||||||||
Lease expirations:(1) | ||||||||||||||||||||||||||||||||||||
Expiring rates | $42.88 | $44.46 | $42.98 | $45.33 | $39.99 | $41.71 | ||||||||||||||||||||||||||||||
Rentable square footage | 738,569 | 2,811,021 | 2,919,259 | |||||||||||||||||||||||||||||||||
(1) | Excludes month-to-month leases aggregating 50,548 RSF and 37,006 RSF as of December 31, 2018, and 2017, respectively. |
(2) | Includes rental rate increases related to the early re-leasing and re-tenanting of space subject to significantly below-market leases at our Alexandria Center® at One Kendall Square campus in our Cambridge submarket. Excluding amortization of acquired below-market leases on renewed/re-leased space at our Alexandria Center® at One Kendall Square campus, rental rate change for the three months ended December 31, 2018 was 24.1%. |
(3) | During the year ended December 31, 2018, we granted tenant concessions/free rent averaging 2.2 months with respect to the 4,721,692 RSF leased. Approximately 58% of the leases executed during the year ended December 31, 2018, did not include concessions for free rent. |
![]() | |
Contractual Lease Expirations | |
December 31, 2018 | |
Year | Number of Leases | RSF | Percentage of Occupied RSF | Annual Rental Revenue (per RSF)(1) | Percentage of Total Annual Rental Revenue | ||||||||||||||||||||||||
2019 | (2) | 94 | 1,232,553 | 5.7 | % | $ | 43.36 | 5.2 | % | ||||||||||||||||||||
2020 | 116 | 1,766,578 | 8.1 | % | $ | 37.43 | 6.4 | % | |||||||||||||||||||||
2021 | 92 | 1,492,897 | 6.9 | % | $ | 39.47 | 5.7 | % | |||||||||||||||||||||
2022 | 89 | 1,733,458 | 8.0 | % | $ | 42.15 | 7.1 | % | |||||||||||||||||||||
2023 | 84 | 2,279,590 | 10.5 | % | $ | 43.23 | 9.5 | % | |||||||||||||||||||||
2024 | 59 | 1,868,399 | 8.6 | % | $ | 47.69 | 8.6 | % | |||||||||||||||||||||
2025 | 36 | 1,500,433 | 6.9 | % | $ | 47.52 | 6.9 | % | |||||||||||||||||||||
2026 | 27 | 933,745 | 4.3 | % | $ | 42.40 | 3.8 | % | |||||||||||||||||||||
2027 | 24 | 1,928,376 | 8.9 | % | $ | 43.85 | 8.2 | % | |||||||||||||||||||||
2028 | 25 | 1,530,627 | 7.0 | % | $ | 59.94 | 8.9 | % | |||||||||||||||||||||
Thereafter | 37 | 5,449,007 | 25.1 | % | $ | 56.58 | 29.7 | % | |||||||||||||||||||||
Market | 2019 Contractual Lease Expirations (in RSF) | Annual Rental Revenue (per RSF)(1) | 2020 Contractual Lease Expirations (in RSF) | Annual Rental Revenue (per RSF)(1) | ||||||||||||||||||||||||||||||||||||||
Leased | Negotiating/ Anticipating | Targeted for Redevelopment | Remaining Expiring Leases(3) | Total(2) | Leased | Negotiating/ Anticipating | Targeted for Redevelopment | Remaining Expiring Leases | Total | |||||||||||||||||||||||||||||||||
Greater Boston | 129,890 | 18,507 | — | 199,689 | 348,086 | $ | 55.41 | 69,673 | — | — | 444,742 | (4) | 514,415 | $ | 45.84 | |||||||||||||||||||||||||||
San Francisco | 83,817 | 60,605 | — | 115,790 | 260,212 | 41.80 | 16,759 | — | — | 280,176 | 296,935 | 41.67 | ||||||||||||||||||||||||||||||
New York City | — | — | — | 8,931 | 8,931 | N/A | — | — | — | 46,461 | 46,461 | 88.91 | ||||||||||||||||||||||||||||||
San Diego | 114,952 | — | — | 165,969 | 280,921 | 32.32 | 679 | — | — | 252,678 | 253,357 | 28.09 | ||||||||||||||||||||||||||||||
Seattle | 106,003 | — | — | 56,179 | 162,182 | 45.82 | — | — | — | 143,068 | 143,068 | 50.53 | ||||||||||||||||||||||||||||||
Maryland | 14,933 | 14,075 | — | 46,621 | 75,629 | 26.82 | — | 18,468 | — | 267,856 | 286,324 | 23.17 | ||||||||||||||||||||||||||||||
Research Triangle Park | — | 7,685 | — | 25,787 | 33,472 | 23.25 | — | — | — | 119,503 | 119,503 | 16.48 | ||||||||||||||||||||||||||||||
Canada | — | — | — | — | — | — | 54,941 | — | — | 43,976 | 98,917 | 28.78 | ||||||||||||||||||||||||||||||
Non-cluster markets | 3,508 | 11,247 | — | 48,365 | 63,120 | 26.15 | — | — | — | 7,598 | 7,598 | 25.37 | ||||||||||||||||||||||||||||||
Total | 453,103 | 112,119 | — | 667,331 | 1,232,553 | $ | 43.36 | 142,052 | 18,468 | — | 1,606,058 | 1,766,578 | $ | 37.43 | ||||||||||||||||||||||||||||
Percentage of expiring leases | 37 | % | 9 | % | — | % | 54 | % | 100 | % | 8 | % | 1 | % | — | % | 91 | % | 100 | % | ||||||||||||||||||||||
(1) | Represents amounts in effect as of December 31, 2018. |
(2) | Excludes month-to-month leases aggregating 50,548 RSF as of December 31, 2018. |
(3) | Includes 116,556 RSF expiring in June 2019 at 3545 Cray Court in our Torrey Pines submarket, which is under evaluation for options to renovate as a Class A office/laboratory building. Any renovation we may undertake at this property will not be classified as a redevelopment, and as such the property will remain in our same properties. The next largest contractual lease expiration in 2019 is 50,400 RSF, which is under evaluation for renewal. |
(4) | Includes 223,007 RSF, or 50%, of 444,742 RSF of remaining expiring leases in 2020 that are located in our Cambridge submarket. The largest contractual remaining expiring lease in 2020 is 36,309 RSF at 215 First Street. |
Top 20 Tenants | ![]() |
December 31, 2018 | |
(Dollars in thousands, except average market cap amounts) | |
Tenant | Remaining Lease Term in Years(1) | Aggregate RSF | Annual Rental Revenue(1) | Percentage of Aggregate Annual Rental Revenue(1) | Investment-Grade Credit Ratings | Average Market Cap(2) (in billions) | ||||||||||||||||||||||||
Moody’s | S&P | |||||||||||||||||||||||||||||
1 | Takeda Pharmaceutical Company Ltd. | 11.0 | 549,759 | $ | 37,142 | 3.6 | % | Baa2 | A- | $ | 35.3 | |||||||||||||||||||
2 | Illumina, Inc. | 11.6 | 891,495 | 34,830 | 3.3 | — | BBB | $ | 42.1 | |||||||||||||||||||||
3 | Sanofi | 9.2 | 494,693 | 30,324 | 2.9 | A1 | AA | $ | 105.2 | |||||||||||||||||||||
4 | Eli Lilly and Company | 10.9 | 467,521 | 29,203 | 2.8 | A2 | AA- | $ | 101.2 | |||||||||||||||||||||
5 | Celgene Corporation(3) | 7.4 | 614,082 | 29,201 | 2.8 | Baa2 | BBB+ | $ | 62.2 | |||||||||||||||||||||
6 | Novartis AG | 8.1 | 361,180 | 27,724 | 2.7 | A1 | AA- | $ | 213.3 | |||||||||||||||||||||
7 | Bristol-Myers Squibb Company(3) | 10.4 | 378,295 | 26,746 | 2.6 | A2 | A+ | $ | 94.4 | |||||||||||||||||||||
8 | Merck & Co., Inc. | 12.1 | 454,752 | 25,439 | 2.4 | A1 | AA | $ | 171.3 | |||||||||||||||||||||
9 | Uber Technologies, Inc. | 73.9 | (4) | 422,980 | 22,197 | 2.1 | — | — | $ | — | ||||||||||||||||||||
10 | bluebird bio, Inc. | 8.1 | 262,261 | 20,100 | 1.9 | — | — | $ | 8.3 | |||||||||||||||||||||
11 | Moderna Therapeutics, Inc. | 9.9 | 356,975 | 19,857 | 1.9 | — | — | $ | 5.4 | |||||||||||||||||||||
12 | New York University | 12.4 | 203,666 | 19,544 | 1.9 | Aa2 | AA- | $ | — | |||||||||||||||||||||
13 | Roche | 4.9 | 366,996 | 19,524 | 1.9 | Aa3 | AA | $ | 204.9 | |||||||||||||||||||||
14 | Stripe, Inc. | 8.8 | 295,333 | 17,736 | 1.7 | — | — | $ | — | |||||||||||||||||||||
15 | Pfizer Inc. | 5.8 | 416,226 | 17,410 | 1.7 | A1 | AA | $ | 230.0 | |||||||||||||||||||||
16 | Amgen Inc. | 5.3 | 407,369 | 16,838 | 1.6 | Baa1 | A | $ | 125.9 | |||||||||||||||||||||
17 | Massachusetts Institute of Technology | 6.5 | 256,126 | 16,729 | 1.6 | Aaa | AAA | $ | — | |||||||||||||||||||||
18 | Facebook, Inc. | 11.4 | 382,883 | 16,262 | 1.6 | — | — | $ | 495.6 | |||||||||||||||||||||
19 | United States Government | 9.2 | 264,358 | 15,428 | 1.5 | Aaa | AA+ | $ | — | |||||||||||||||||||||
20 | FibroGen, Inc. | 4.9 | 234,249 | 14,198 | 1.4 | — | — | $ | 4.4 | |||||||||||||||||||||
Total/weighted average | 12.3 | (4) | 8,081,199 | $ | 456,432 | 43.9 | % | |||||||||||||||||||||||
(1) | Based on aggregate annual rental revenue in effect as of December 31, 2018. See “Definitions and Reconciliations” for our methodology on annual rental revenue for unconsolidated properties for additional information. |
(2) | Average daily market capitalization for the 12 months ended December 31, 2018. See “Definitions and Reconciliations” for additional information. |
(3) | In January 2019, Bristol-Myers Squibb Company entered into a definitive agreement to acquire Celgene Corporation. The transaction is expected to close in 3Q19, subject to the approval of Bristol-Myers Squibb Company and Celgene Corporation shareholders. Our lease to Bristol-Myers Squibb Company at 1208 Eastlake Avenue East in our Lake Union submarket expired on December 31, 2018, and we have re-leased 78% of the expired 97,366 RSF to a life science pharmaceutical company. Bristol-Myers Squibb Company also currently leases 106,003 RSF at 1201 Eastlake Avenue East in our Lake Union submarket that expires during the first half of 2019 and we have re-leased 100% of this RSF to an investment-grade institutional research center. Subsequent to the close of the transaction, our future remaining annual rental revenue from Bristol-Myers Squibb Company is expected to be approximately 4.7%. |
(4) | Represents a ground lease with Uber Technologies, Inc. at 1455 and 1515 Third Street in our Mission Bay/SoMa submarket. Excluding the ground lease, the weighted-average remaining lease term for our top 20 tenants was 9.2 years as of December 31, 2018. |
Summary of Properties and Occupancy | ![]() |
December 31, 2018 | |
(Dollars in thousands, except per RSF amounts) | |
Market | RSF | Number of Properties | Annual Rental Revenue | |||||||||||||||||||||||||||
Operating | Development | Redevelopment | Total | % of Total | Total | % of Total | Per RSF | |||||||||||||||||||||||
Greater Boston | 6,236,036 | 164,000 | 31,858 | 6,431,894 | 26 | % | 55 | $ | 383,817 | 37 | % | $ | 62.36 | |||||||||||||||||
San Francisco | 4,818,806 | 1,326,158 | 190,947 | 6,335,911 | 26 | 44 | 241,111 | 23 | 51.71 | |||||||||||||||||||||
New York City | 1,114,282 | — | 140,098 | 1,254,380 | 5 | 4 | 78,430 | 7 | 71.58 | |||||||||||||||||||||
San Diego | 4,776,849 | — | — | 4,776,849 | 20 | 58 | 172,025 | 16 | 38.05 | |||||||||||||||||||||
Seattle | 1,235,055 | 198,000 | — | 1,433,055 | 6 | 13 | 60,477 | 6 | 50.13 | |||||||||||||||||||||
Maryland | 2,509,994 | — | 55,347 | 2,565,341 | 10 | 37 | 67,820 | 6 | 28.04 | |||||||||||||||||||||
Research Triangle Park | 1,097,249 | — | 121,477 | 1,218,726 | 5 | 16 | 27,830 | 3 | 26.58 | |||||||||||||||||||||
Canada | 256,967 | — | — | 256,967 | 1 | 3 | 7,284 | 1 | 29.77 | |||||||||||||||||||||
Non-cluster markets | 314,315 | — | — | 314,315 | 1 | 7 | 7,158 | 1 | 28.82 | |||||||||||||||||||||
North America | 22,359,553 | 1,688,158 | 539,727 | 24,587,438 | 100 | % | 237 | $ | 1,045,952 | 100 | % | $ | 48.42 | |||||||||||||||||
2,227,885 | ||||||||||||||||||||||||||||||
Operating Properties | Operating and Redevelopment Properties | |||||||||||||||||
Market | 12/31/18 | 9/30/18 | 12/31/17 | 12/31/18 | 9/30/18 | 12/31/17 | ||||||||||||
Greater Boston | 98.7 | % | 98.4 | % | 96.6 | % | 98.2 | % | 97.9 | % | 95.7 | % | ||||||
San Francisco | 100.0 | 100.0 | 99.6 | 96.2 | 95.9 | 99.6 | ||||||||||||
New York City | 98.3 | 97.2 | 99.8 | 87.3 | 97.2 | 99.8 | ||||||||||||
San Diego | 94.7 | 94.2 | 94.5 | 94.7 | 90.8 | 90.9 | ||||||||||||
Seattle | 97.7 | 97.6 | 97.7 | 97.7 | 97.6 | 97.7 | ||||||||||||
Maryland | 96.8 | 97.2 | 95.2 | 94.7 | 93.3 | 93.2 | ||||||||||||
Research Triangle Park | 95.4 | 96.6 | 98.1 | 85.9 | 86.3 | 84.0 | ||||||||||||
Subtotal | 97.6 | 97.5 | 97.0 | 95.3 | 94.7 | 94.9 | ||||||||||||
Canada | 95.2 | 98.6 | 99.6 | 95.2 | 98.6 | 99.6 | ||||||||||||
Non-cluster markets | 79.0 | 82.2 | 78.4 | 79.0 | 82.2 | 78.4 | ||||||||||||
North America | 97.3 | % | 97.3 | % | 96.8 | % | 95.1 | % | 94.6 | % | 94.7 | % | ||||||
Property Listing | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Market / Submarket / Address | RSF | Number of Properties | Annual Rental Revenue | Occupancy Percentage | ||||||||||||||||||||||||
Operating | Operating and Redevelopment | |||||||||||||||||||||||||||
Operating | Development | Redevelopment | Total | |||||||||||||||||||||||||
Greater Boston | ||||||||||||||||||||||||||||
Cambridge/Inner Suburbs | ||||||||||||||||||||||||||||
Alexandria Center® at Kendall Square | 2,365,487 | — | — | 2,365,487 | 10 | $ | 162,570 | 98.8 | % | 98.8 | % | |||||||||||||||||
50, 60, 75/125, and 100 Binney Street, 225 Binney Street(1), 161 First Street, 215 First Street, 150 Second Street, 300 Third Street, and 11 Hurley Street | ||||||||||||||||||||||||||||
Alexandria Technology Square® | 1,181,635 | — | — | 1,181,635 | 7 | 88,137 | 99.8 | 99.8 | ||||||||||||||||||||
100, 200, 300, 400, 500, 600, and 700 Technology Square | ||||||||||||||||||||||||||||
Alexandria Center® at One Kendall Square | 649,705 | 164,000 | — | 813,705 | 10 | 49,606 | 95.2 | ` | 95.2 | |||||||||||||||||||
One Kendall Square – Buildings 100, 200, 300, 400, 500, 600/700, 1400, 1800, 2000, and 399 Binney Street | ||||||||||||||||||||||||||||
480 and 500 Arsenal Street | 234,260 | — | — | 234,260 | 2 | 10,647 | 100.0 | 100.0 | ||||||||||||||||||||
640 Memorial Drive | 225,504 | — | — | 225,504 | 1 | 13,771 | 100.0 | 100.0 | ||||||||||||||||||||
780 and 790 Memorial Drive | 99,658 | — | — | 99,658 | 2 | 7,779 | 100.0 | 100.0 | ||||||||||||||||||||
167 Sidney Street and 99 Erie Street | 54,549 | — | — | 54,549 | 2 | 4,014 | 100.0 | 100.0 | ||||||||||||||||||||
79/96 13th Street (Charlestown Navy Yard) | 25,309 | — | — | 25,309 | 1 | 620 | 100.0 | 100.0 | ||||||||||||||||||||
Cambridge/Inner Suburbs | 4,836,107 | 164,000 | — | 5,000,107 | 35 | 337,144 | 98.7 | 98.7 | ||||||||||||||||||||
Seaport Innovation District | ||||||||||||||||||||||||||||
99 A Street | 8,715 | — | — | 8,715 | 1 | 850 | 100.0 | 100.0 | ||||||||||||||||||||
Route 128 | ||||||||||||||||||||||||||||
Alexandria Park at 128 | 343,882 | — | — | 343,882 | 8 | 10,503 | 95.6 | 95.6 | ||||||||||||||||||||
3 and 6/8 Preston Court, 29, 35, and 44 Hartwell Avenue, 35 and 45/47 Wiggins Avenue, and 60 Westview Street | ||||||||||||||||||||||||||||
225, 266, and 275 Second Avenue | 285,759 | — | 31,858 | 317,617 | 3 | 12,328 | 100.0 | 90.0 | ||||||||||||||||||||
100 Tech Drive | 200,431 | — | — | 200,431 | 1 | 8,455 | 100.0 | 100.0 | ||||||||||||||||||||
19 Presidential Way | 144,892 | — | — | 144,892 | 1 | 5,134 | 96.8 | 96.8 | ||||||||||||||||||||
100 Beaver Street | 82,330 | — | — | 82,330 | 1 | 3,279 | 100.0 | 100.0 | ||||||||||||||||||||
285 Bear Hill Road | 26,270 | — | — | 26,270 | 1 | 1,167 | 100.0 | 100.0 | ||||||||||||||||||||
Route 128 | 1,083,564 | — | 31,858 | 1,115,422 | 15 | 40,866 | 98.2 | 95.4 | ||||||||||||||||||||
Route 495 | ||||||||||||||||||||||||||||
111 and 130 Forbes Boulevard | 155,846 | — | — | 155,846 | 2 | 1,543 | 100.0 | 100.0 | ||||||||||||||||||||
20 Walkup Drive | 91,045 | — | — | 91,045 | 1 | 649 | 100.0 | 100.0 | ||||||||||||||||||||
30 Bearfoot Road | 60,759 | — | — | 60,759 | 1 | 2,765 | 100.0 | 100.0 | ||||||||||||||||||||
Route 495 | 307,650 | — | — | 307,650 | 4 | 4,957 | 100.0 | 100.0 | ||||||||||||||||||||
Greater Boston | 6,236,036 | 164,000 | 31,858 | 6,431,894 | 55 | $ | 383,817 | 98.7 | % | 98.2 | % | |||||||||||||||||
(1) We own a partial interest in this property through a real estate joint venture. See “Joint Venture Financial Information” of this Supplemental Information for additional information. | ||||||||||||||||||||||||||||
Property Listing (continued) | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Market / Submarket / Address | RSF | Number of Properties | Annual Rental Revenue | Occupancy Percentage | ||||||||||||||||||||||||
Operating | Operating and Redevelopment | |||||||||||||||||||||||||||
Operating | Development | Redevelopment | Total | |||||||||||||||||||||||||
San Francisco | ||||||||||||||||||||||||||||
Mission Bay/SoMa | ||||||||||||||||||||||||||||
1655 and 1725 Third Street(1) | — | 593,765 | — | 593,765 | 2 | $ | — | N/A | N/A | |||||||||||||||||||
409 and 499 Illinois Street(1) | 455,069 | — | — | 455,069 | 2 | 28,698 | 100.0 | % | 100.0 | % | ||||||||||||||||||
1455 and 1515 Third Street | 422,980 | — | — | 422,980 | 2 | 22,197 | 100.0 | 100.0 | ||||||||||||||||||||
510 Townsend Street | 295,333 | — | — | 295,333 | 1 | 17,736 | 100.0 | 100.0 | ||||||||||||||||||||
88 Bluxome Street | 232,470 | — | — | 232,470 | 1 | 3,813 | 100.0 | 100.0 | ||||||||||||||||||||
455 Mission Bay Boulevard South | 210,398 | — | — | 210,398 | 1 | 13,192 | 100.0 | 100.0 | ||||||||||||||||||||
1500 Owens Street(1) | 158,267 | — | — | 158,267 | 1 | 7,681 | 100.0 | 100.0 | ||||||||||||||||||||
1700 Owens Street | 157,340 | — | — | 157,340 | 1 | 11,097 | 99.9 | 99.9 | ||||||||||||||||||||
505 Brannan Street | 148,146 | — | — | 148,146 | 1 | 12,093 | 100.0 | 100.0 | ||||||||||||||||||||
Mission Bay/SoMa | 2,080,003 | 593,765 | — | 2,673,768 | 12 | 116,507 | 100.0 | 100.0 | ||||||||||||||||||||
South San Francisco | ||||||||||||||||||||||||||||
213, 249, 259, 269, and 279 East Grand Avenue | 708,299 | 211,405 | — | 919,704 | 5 | 35,751 | 100.0 | 100.0 | ||||||||||||||||||||
Alexandria Technology Center® – Gateway | 492,066 | — | 142,400 | 634,466 | 7 | 23,251 | 100.0 | 77.6 | ||||||||||||||||||||
600, 630, 650, 681, 701, 901, and 951 Gateway Boulevard | ||||||||||||||||||||||||||||
400 and 450 East Jamie Court | 163,035 | — | — | 163,035 | 2 | 6,519 | 100.0 | 100.0 | ||||||||||||||||||||
500 Forbes Boulevard | 155,685 | — | — | 155,685 | 1 | 6,619 | 100.0 | 100.0 | ||||||||||||||||||||
7000 Shoreline Court | 136,395 | — | — | 136,395 | 1 | 5,692 | 100.0 | 100.0 | ||||||||||||||||||||
341 and 343 Oyster Point Boulevard | 107,960 | — | — | 107,960 | 2 | 4,479 | 100.0 | 100.0 | ||||||||||||||||||||
849/863 Mitten Road/866 Malcolm Road | 103,857 | — | — | 103,857 | 1 | 3,979 | 100.0 | 100.0 | ||||||||||||||||||||
South San Francisco | 1,867,297 | 211,405 | 142,400 | 2,221,102 | 19 | 86,290 | 100.0 | 92.9 | ||||||||||||||||||||
Greater Stanford | ||||||||||||||||||||||||||||
Menlo Gateway(1) | 251,995 | 520,988 | — | 772,983 | 3 | 7,153 | 100.0 | 100.0 | ||||||||||||||||||||
100 Independence Drive and 125 and 135 Constitution Drive | ||||||||||||||||||||||||||||
Alexandria PARC | 148,951 | — | 48,547 | 197,498 | 4 | 8,297 | 100.0 | 75.4 | ||||||||||||||||||||
2100, 2200, 2300, and 2400 Geng Road | ||||||||||||||||||||||||||||
960 Industrial Road | 110,000 | — | — | 110,000 | 1 | 2,749 | 100.0 | 100.0 | ||||||||||||||||||||
2425 Garcia Avenue/2400/2450 Bayshore Parkway | 99,208 | — | — | 99,208 | 1 | 4,257 | 100.0 | 100.0 | ||||||||||||||||||||
3165 Porter Drive | 91,644 | — | — | 91,644 | 1 | 3,885 | 100.0 | 100.0 | ||||||||||||||||||||
1450 Page Mill Road | 77,634 | — | — | 77,634 | 1 | 8,009 | 100.0 | 100.0 | ||||||||||||||||||||
3350 West Bayshore Road | 60,000 | — | — | 60,000 | 1 | 2,211 | 100.0 | 100.0 | ||||||||||||||||||||
2625/2627/2631 Hanover Street | 32,074 | — | — | 32,074 | 1 | 1,753 | 100.0 | 100.0 | ||||||||||||||||||||
Greater Stanford | 871,506 | 520,988 | 48,547 | 1,441,041 | 13 | 38,314 | 100.0 | 94.7 | ||||||||||||||||||||
San Francisco | 4,818,806 | 1,326,158 | 190,947 | 6,335,911 | 44 | 241,111 | 100.0 | 96.2 | ||||||||||||||||||||
New York City | ||||||||||||||||||||||||||||
New York City | ||||||||||||||||||||||||||||
Alexandria Center® for Life Science – New York City | 727,674 | — | — | 727,674 | 2 | 63,407 | 97.4 | 97.4 | ||||||||||||||||||||
430 and 450 East 29th Street | ||||||||||||||||||||||||||||
219 East 42nd Street | 349,947 | — | — | 349,947 | 1 | 14,006 | 100.0 | 100.0 | ||||||||||||||||||||
Alexandria Life Science Factory at Long Island City | 36,661 | — | 140,098 | 176,759 | 1 | 1,017 | 100.0 | 20.7 | ||||||||||||||||||||
30-02 48th Avenue | ||||||||||||||||||||||||||||
New York City | 1,114,282 | — | 140,098 | 1,254,380 | 4 | $ | 78,430 | 98.3 | % | 87.3 | % | |||||||||||||||||
(1) We own a partial interest in this property through a real estate joint venture. See “Joint Venture Financial Information” of this Supplemental Information for additional information. | ||||||||||||||||||||||||||||
Property Listing (continued) | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Market / Submarket / Address | RSF | Number of Properties | Annual Rental Revenue | Occupancy Percentage | ||||||||||||||||||||||||
Operating | Operating and Redevelopment | |||||||||||||||||||||||||||
Operating | Development | Redevelopment | Total | |||||||||||||||||||||||||
San Diego | ||||||||||||||||||||||||||||
Torrey Pines | ||||||||||||||||||||||||||||
ARE Spectrum | 336,461 | — | — | 336,461 | 3 | $ | 17,173 | 100.0 | % | 100.0 | % | |||||||||||||||||
3215 Merryfield Row and 3013 and 3033 Science Park Road | ||||||||||||||||||||||||||||
ARE Torrey Ridge | 294,993 | — | — | 294,993 | 3 | 13,271 | 89.6 | 89.6 | ||||||||||||||||||||
10578, 10614, and 10628 Science Center Drive | ||||||||||||||||||||||||||||
ARE Sunrise | 236,635 | — | — | 236,635 | 3 | 8,834 | 100.0 | 100.0 | ||||||||||||||||||||
10931/10933 and 10975 North Torrey Pines Road, 3010 Science Park Road, and 10996 Torreyana Road | ||||||||||||||||||||||||||||
ARE Nautilus | 223,751 | — | — | 223,751 | 4 | 10,599 | 100.0 | 100.0 | ||||||||||||||||||||
3530 and 3550 John Hopkins Court and 3535 and 3565 General Atomics Court | ||||||||||||||||||||||||||||
3545 Cray Court | 116,556 | — | — | 116,556 | 1 | 4,827 | 100.0 | 100.0 | ||||||||||||||||||||
11119 North Torrey Pines Road | 72,506 | — | — | 72,506 | 1 | 3,409 | 100.0 | 100.0 | ||||||||||||||||||||
Torrey Pines | 1,280,902 | — | — | 1,280,902 | 15 | 58,113 | 97.6 | 97.6 | ||||||||||||||||||||
University Town Center | ||||||||||||||||||||||||||||
Campus Pointe by Alexandria | 1,067,847 | — | — | 1,067,847 | 5 | 36,539 | 92.6 | 92.6 | ||||||||||||||||||||
10260 Campus Point Drive, 10290 and 10300 Campus Point Drive(1), 4110 Campus Point Court(1), and 4161 Campus Point Court | ||||||||||||||||||||||||||||
5200 Illumina Way | 792,687 | — | — | 792,687 | 6 | 28,901 | 100.0 | 100.0 | ||||||||||||||||||||
ARE Esplanade | 241,963 | — | — | 241,963 | 4 | 10,036 | 100.0 | 100.0 | ||||||||||||||||||||
4755, 4757, and 4767 Nexus Center Drive and 4796 Executive Drive | ||||||||||||||||||||||||||||
ARE Towne Centre | 304,046 | — | — | 304,046 | 4 | 8,249 | 85.9 | 85.9 | ||||||||||||||||||||
9363, 9373, and 9393 Towne Centre Drive and 9625 Towne Centre Drive(1) | ||||||||||||||||||||||||||||
University Town Center | 2,406,543 | — | — | 2,406,543 | 19 | 83,725 | 94.9 | 94.9 | ||||||||||||||||||||
Sorrento Mesa | ||||||||||||||||||||||||||||
Summers Ridge Science Park | 316,531 | — | — | 316,531 | 4 | 10,843 | 100.0 | 100.0 | ||||||||||||||||||||
9965, 9975, 9985, and 9995 Summers Ridge Road | ||||||||||||||||||||||||||||
5810/5820 and 6138/6150 Nancy Ridge Drive | 138,970 | — | — | 138,970 | 2 | 2,364 | 59.2 | 59.2 | ||||||||||||||||||||
10121 and 10151 Barnes Canyon Road | 102,392 | — | — | 102,392 | 2 | 2,689 | 100.0 | 100.0 | ||||||||||||||||||||
ARE Portola | 101,857 | — | — | 101,857 | 3 | 3,234 | 100.0 | 100.0 | ||||||||||||||||||||
6175, 6225, and 6275 Nancy Ridge Drive | ||||||||||||||||||||||||||||
7330 Carroll Road | 66,244 | — | — | 66,244 | 1 | 2,431 | 100.0 | 100.0 | ||||||||||||||||||||
5871 Oberlin Drive | 33,817 | — | — | 33,817 | 1 | 832 | 86.8 | 86.8 | ||||||||||||||||||||
Sorrento Mesa | 759,811 | — | — | 759,811 | 13 | 22,393 | 92.0 | 92.0 | ||||||||||||||||||||
Sorrento Valley | ||||||||||||||||||||||||||||
11025, 11035, 11045, 11055, 11065, and 11075 Roselle Street | 121,655 | — | — | 121,655 | 6 | 2,262 | 74.6 | 74.6 | ||||||||||||||||||||
3985, 4025, 4031, and 4045 Sorrento Valley Boulevard | 98,158 | — | — | 98,158 | 4 | 2,560 | 88.9 | 88.9 | ||||||||||||||||||||
Sorrento Valley | 219,813 | — | — | 219,813 | 10 | 4,822 | 81.0 | 81.0 | ||||||||||||||||||||
I-15 Corridor | ||||||||||||||||||||||||||||
13112 Evening Creek Drive | 109,780 | — | — | 109,780 | 1 | 2,972 | 100.0 | 100.0 | ||||||||||||||||||||
San Diego | 4,776,849 | — | — | 4,776,849 | 58 | $ | 172,025 | 94.7 | % | 94.7 | % | |||||||||||||||||
(1) We own a partial interest in this property through a real estate joint venture. See “Joint Venture Financial Information” of this Supplemental Information for additional information. | ||||||||||||||||||||||||||||
Property Listing (continued) | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Market / Submarket / Address | RSF | Number of Properties | Annual Rental Revenue | Occupancy Percentage | ||||||||||||||||||||||||
Operating | Operating and Redevelopment | |||||||||||||||||||||||||||
Operating | Development | Redevelopment | Total | |||||||||||||||||||||||||
Seattle | ||||||||||||||||||||||||||||
Lake Union | ||||||||||||||||||||||||||||
400 Dexter Avenue North | 290,111 | — | — | 290,111 | 1 | $ | 15,068 | 100.0 | % | 100.0 | % | |||||||||||||||||
1201 and 1208 Eastlake Avenue East | 203,369 | — | — | 203,369 | 2 | 10,193 | 100.0 | 100.0 | ||||||||||||||||||||
188 East Blaine Street(1) | — | 198,000 | — | 198,000 | 1 | — | N/A | N/A | ||||||||||||||||||||
2301 5th Avenue | 197,135 | — | — | 197,135 | 1 | 10,015 | 97.4 | 97.4 | ||||||||||||||||||||
1616 Eastlake Avenue East | 168,708 | — | — | 168,708 | 1 | 8,287 | 93.8 | 93.8 | ||||||||||||||||||||
1551 Eastlake Avenue East | 117,482 | — | — | 117,482 | 1 | 4,837 | 100.0 | 100.0 | ||||||||||||||||||||
199 East Blaine Street | 115,084 | — | — | 115,084 | 1 | 6,186 | 100.0 | 100.0 | ||||||||||||||||||||
219 Terry Avenue North | 30,705 | — | — | 30,705 | 1 | 1,837 | 100.0 | 100.0 | ||||||||||||||||||||
1600 Fairview Avenue East | 27,991 | — | — | 27,991 | 1 | 1,245 | 100.0 | 100.0 | ||||||||||||||||||||
Lake Union | 1,150,585 | 198,000 | — | 1,348,585 | 10 | 57,668 | 98.7 | 98.7 | ||||||||||||||||||||
Elliott Bay | ||||||||||||||||||||||||||||
3000/3018 Western Avenue | 47,746 | — | — | 47,746 | 1 | 1,839 | 100.0 | 100.0 | ||||||||||||||||||||
410 West Harrison Street and 410 Elliott Avenue West | 36,724 | — | — | 36,724 | 2 | 970 | 63.9 | 63.9 | ||||||||||||||||||||
Elliott Bay | 84,470 | — | — | 84,470 | 3 | 2,809 | 84.3 | 84.3 | ||||||||||||||||||||
Seattle | 1,235,055 | 198,000 | — | 1,433,055 | 13 | 60,477 | 97.7 | 97.7 | ||||||||||||||||||||
Maryland | ||||||||||||||||||||||||||||
Rockville | ||||||||||||||||||||||||||||
9800, 9900, and 9920 Medical Center Drive | 386,208 | — | — | 386,208 | 6 | 14,105 | 95.1 | 95.1 | ||||||||||||||||||||
9704, 9708, 9712, and 9714 Medical Center Drive | 214,725 | — | — | 214,725 | 4 | 7,862 | 100.0 | 100.0 | ||||||||||||||||||||
1330 Piccard Drive | 131,511 | — | — | 131,511 | 1 | 3,562 | 100.0 | 100.0 | ||||||||||||||||||||
1500 and 1550 East Gude Drive | 90,489 | — | — | 90,489 | 2 | 1,681 | 100.0 | 100.0 | ||||||||||||||||||||
14920 and 15010 Broschart Road | 86,703 | — | — | 86,703 | 2 | 2,260 | 100.0 | 100.0 | ||||||||||||||||||||
1405 Research Boulevard | 71,669 | — | — | 71,669 | 1 | 2,334 | 100.0 | 100.0 | ||||||||||||||||||||
5 Research Place | 63,852 | — | — | 63,852 | 1 | 2,734 | 100.0 | 100.0 | ||||||||||||||||||||
9920 Belward Campus Drive | 51,181 | — | — | 51,181 | 1 | 1,568 | 100.0 | 100.0 | ||||||||||||||||||||
12301 Parklawn Drive | 49,185 | — | — | 49,185 | 1 | 1,329 | 100.0 | 100.0 | ||||||||||||||||||||
5 Research Court | 49,160 | — | — | 49,160 | 1 | — | — | — | ||||||||||||||||||||
Rockville | 1,194,683 | — | — | 1,194,683 | 20 | 37,435 | 94.3 | 94.3 | ||||||||||||||||||||
Gaithersburg | ||||||||||||||||||||||||||||
Alexandria Technology Center® – Gaithersburg I | 377,585 | — | — | 377,585 | 4 | 9,411 | 100.0 | 100.0 | ||||||||||||||||||||
9 West Watkins Mill Road and 910, 930, and 940 Clopper Road | ||||||||||||||||||||||||||||
Alexandria Technology Center® – Gaithersburg II | 259,637 | — | 55,347 | 314,984 | 6 | 6,894 | 97.7 | 80.6 | ||||||||||||||||||||
704 Quince Orchard Road(2), 708 Quince Orchard Road, and 19, 20, 21, and 22 Firstfield Road | ||||||||||||||||||||||||||||
50 and 55 West Watkins Mill Road | 96,915 | — | — | 96,915 | 2 | 2,706 | 100.0 | 100.0 | ||||||||||||||||||||
401 Professional Drive | 63,154 | — | — | 63,154 | 1 | 1,602 | 100.0 | 100.0 | ||||||||||||||||||||
950 Wind River Lane | 50,000 | — | — | 50,000 | 1 | 1,004 | 100.0 | 100.0 | ||||||||||||||||||||
620 Professional Drive | 27,950 | — | — | 27,950 | 1 | 1,191 | 100.0 | 100.0 | ||||||||||||||||||||
Gaithersburg | 875,241 | — | 55,347 | 930,588 | 15 | $ | 22,808 | 99.3 | % | 93.4 | % | |||||||||||||||||
(1) Formerly 1818 Fairview Avenue East. (2) We own a partial interest in this property through a real estate joint venture. See “Joint Venture Financial Information” of this Supplemental Information for additional information. | ||||||||||||||||||||||||||||
Property Listing (continued) | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Market / Submarket / Address | RSF | Number of Properties | Annual Rental Revenue | Occupancy Percentage | ||||||||||||||||||||||||
Operating | Operating and Redevelopment | |||||||||||||||||||||||||||
Operating | Development | Redevelopment | Total | |||||||||||||||||||||||||
Maryland (continued) | ||||||||||||||||||||||||||||
Beltsville | ||||||||||||||||||||||||||||
8000/9000/10000 Virginia Manor Road | 191,884 | — | — | 191,884 | 1 | $ | 2,439 | 96.6 | % | 96.6 | % | |||||||||||||||||
Northern Virginia | ||||||||||||||||||||||||||||
14225 Newbrook Drive | 248,186 | — | — | 248,186 | 1 | 5,138 | 100.0 | 100.0 | ||||||||||||||||||||
Maryland | 2,509,994 | — | 55,347 | 2,565,341 | 37 | 67,820 | 96.8 | 94.7 | ||||||||||||||||||||
Research Triangle Park | ||||||||||||||||||||||||||||
Research Triangle Park | ||||||||||||||||||||||||||||
Alexandria Technology Center® – Alston | 186,870 | — | — | 186,870 | 3 | 3,559 | 92.3 | 92.3 | ||||||||||||||||||||
100, 800, and 801 Capitola Drive | ||||||||||||||||||||||||||||
Alexandria Center® for AgTech – RTP | 53,523 | — | 121,477 | 175,000 | 1 | 1,499 | 100.0 | 30.6 | ||||||||||||||||||||
5 Laboratory Drive | ||||||||||||||||||||||||||||
108/110/112/114 TW Alexander Drive | 158,417 | — | — | 158,417 | 1 | 4,682 | 100.0 | 100.0 | ||||||||||||||||||||
Alexandria Innovation Center® – Research Triangle Park | 135,677 | — | — | 135,677 | 3 | 3,566 | 97.8 | 97.8 | ||||||||||||||||||||
7010, 7020, and 7030 Kit Creek Road | ||||||||||||||||||||||||||||
6 Davis Drive | 100,000 | — | — | 100,000 | 1 | 1,498 | 81.9 | 81.9 | ||||||||||||||||||||
7 Triangle Drive | 96,626 | — | — | 96,626 | 1 | 3,156 | 100.0 | 100.0 | ||||||||||||||||||||
2525 East NC Highway 54 | 82,996 | — | — | 82,996 | 1 | 3,680 | 100.0 | 100.0 | ||||||||||||||||||||
407 Davis Drive | 81,956 | — | — | 81,956 | 1 | 1,644 | 100.0 | 100.0 | ||||||||||||||||||||
601 Keystone Park Drive | 77,395 | — | — | 77,395 | 1 | 1,379 | 100.0 | 100.0 | ||||||||||||||||||||
6040 George Watts Hill Drive | 61,547 | — | — | 61,547 | 1 | 2,148 | 100.0 | 100.0 | ||||||||||||||||||||
5 Triangle Drive | 32,120 | — | — | 32,120 | 1 | 479 | 54.2 | 54.2 | ||||||||||||||||||||
6101 Quadrangle Drive | 30,122 | — | — | 30,122 | 1 | 540 | 100.0 | 100.0 | ||||||||||||||||||||
Research Triangle Park | 1,097,249 | — | 121,477 | 1,218,726 | 16 | 27,830 | 95.4 | 85.9 | ||||||||||||||||||||
Canada | 256,967 | — | — | 256,967 | 3 | 7,284 | 95.2 | 95.2 | ||||||||||||||||||||
Non-cluster markets | 314,315 | — | — | 314,315 | 7 | 7,158 | 79.0 | 79.0 | ||||||||||||||||||||
Total – North America | 22,359,553 | 1,688,158 | 539,727 | 24,587,438 | 237 | $ | 1,045,952 | 97.3 | % | 95.1 | % | |||||||||||||||||
![]() | |
Disciplined Management of Ground-Up Developments | |
December 31, 2018 | |

(1) | Represents developments commenced since January 1, 2008, comprising 28 projects aggregating 7.1 million RSF. |
(2) | Represents developments commenced and delivered since January 1, 2008, comprising 23 projects aggregating 5.5 million RSF. |
Investments in Real Estate | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Investments in Real Estate | Square Footage | ||||||||||||||||||
Investments in real estate: | Operating | Construction | Pre- Construction | Intermediate- Term and Future Projects | Total | ||||||||||||||
Rental properties: | |||||||||||||||||||
Consolidated | $ | 12,588,611 | 22,082,974 | — | — | — | 22,082,974 | ||||||||||||
Unconsolidated(1) | N/A | 276,579 | — | — | — | 276,579 | |||||||||||||
12,588,611 | 22,359,553 | — | — | — | 22,359,553 | ||||||||||||||
New Class A development and redevelopment properties: | |||||||||||||||||||
2019 deliveries | |||||||||||||||||||
Consolidated | 558,675 | — | 1,057,785 | — | — | 1,057,785 | |||||||||||||
Unconsolidated(1) | N/A | — | 1,170,100 | — | — | 1,170,100 | |||||||||||||
2019 deliveries | 558,675 | — | 2,227,885 | — | — | 2,227,885 | |||||||||||||
2020 deliveries | 317,388 | — | — | 1,658,777 | — | 1,658,777 | |||||||||||||
New Class A development and redevelopment properties undergoing construction and pre-construction | 876,063 | — | 2,227,885 | 1,658,777 | — | 3,886,662 | |||||||||||||
Intermediate-term and future development and redevelopment projects: | |||||||||||||||||||
2021-2022 deliveries | 584,751 | — | — | — | 4,737,389 | 4,737,389 | |||||||||||||
Future | 98,802 | — | — | — | 3,083,786 | 3,083,786 | |||||||||||||
Portion of development and redevelopment square feet that will replace existing RSF included in rental properties(2) | N/A | — | — | — | (970,180 | ) | (970,180 | ) | |||||||||||
Intermediate-term and future development and redevelopment projects, excluding RSF related to rental properties | 683,553 | — | — | — | 6,850,995 | 6,850,995 | |||||||||||||
Gross investments in real estate | 14,148,227 | 22,359,553 | 2,227,885 | 1,658,777 | 6,850,995 | 33,097,210 | |||||||||||||
24,587,438 | |||||||||||||||||||
Less: accumulated depreciation | (2,263,797 | ) | |||||||||||||||||
Net investments in real estate – North America | 11,884,430 | ||||||||||||||||||
Net investments in real estate – Asia | 29,263 | ||||||||||||||||||
Investments in real estate | $ | 11,913,693 | |||||||||||||||||
(1) | Our share of the cost basis associated with square footage of our unconsolidated properties is classified in investments in unconsolidated real estate joint ventures in our consolidated balance sheets. | ||||
(2) | Represents RSF of buildings currently in operation that will be redeveloped or replaced with new development RSF upon commencement of future construction, as follows: | ||||
Property/Submarket | RSF | ||||
99 A Street/Seaport Innovation District | 8,715 | ||||
219 East 42nd Street/New York City | 349,947 | ||||
88 Bluxome Street/Mission Bay/SoMa | 232,470 | ||||
960 Industrial Road/Greater Stanford | 110,000 | ||||
10260 Campus Point Drive/University Town Center | 109,164 | ||||
4161 Campus Point Court/University Town Center | 159,884 | ||||
970,180 | |||||
New Class A Development and Redevelopment Properties: Deliveries | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
399 Binney Street | 213 East Grand Avenue | 9625 Towne Centre Drive | 9900 Medical Center Drive | 5 Laboratory Drive | ||||
Greater Boston/Cambridge | San Francisco/South San Francisco | San Diego/University Town Center | Maryland/Rockville | Research Triangle Park/RTP | ||||
123,403 RSF | 300,930 RSF | 163,648 RSF | 45,039 RSF | 53,523 RSF | ||||
Rubius Therapeutics, Inc. Relay Therapeutics, Inc. Celsius Therapeutics, Inc. | Merck & Co., Inc. | Takeda Pharmaceutical Company Ltd. | Lonza Walkersville, Inc. | Boragen, Inc. Elo Life Systems, Inc. Indigo Ag, Inc. | ||||
![]() | ![]() | ![]() | ![]() | |||||
Property/Market/Submarket | Our Ownership Interest | Date Delivered | RSF Placed Into Service | Operating Property Leased Percentage | Total Project | Unlevered Yields | |||||||||||||||||||||||||||||||
Initial Stabilized | Initial Stabilized (Cash) | ||||||||||||||||||||||||||||||||||||
Prior to 10/1/18 | 4Q18 | 1Q19 | Total | RSF | Investment | ||||||||||||||||||||||||||||||||
4Q18 deliveries: | |||||||||||||||||||||||||||||||||||||
Consolidated development projects | |||||||||||||||||||||||||||||||||||||
213 East Grand Avenue/San Francisco/South San Francisco | 100% | 12/31/18 | — | 300,930 | — | 300,930 | 100% | 300,930 | $ | 256,600 | 7.4 | % | 6.5 | % | |||||||||||||||||||||||
Consolidated redevelopment project | |||||||||||||||||||||||||||||||||||||
9625 Towne Centre Drive/San Diego/University Town Center | 50.1% | 11/1/18 | — | 163,648 | — | 163,648 | 100% | 163,648 | $ | 89,000 | 7.3 | % | 7.3 | % | |||||||||||||||||||||||
9900 Medical Center Drive/Maryland/Rockville | 100% | 11/19/18 | — | 45,039 | — | 45,039 | 58% | 45,039 | $ | 16,800 | 8.6 | % | 8.4 | % | |||||||||||||||||||||||
5 Laboratory Drive/Research Triangle Park/RTP | 100% | Various | 45,143 | 8,380 | — | 53,523 | 100% | 175,000 | $ | 62,500 | 7.7 | % | 7.6 | % | |||||||||||||||||||||||
Unconsolidated joint venture redevelopment project | |||||||||||||||||||||||||||||||||||||
704 Quince Orchard Road/Maryland/Gaithersburg | 56.8% | 12/31/18 | — | 4,762 | — | 4,762 | 100% | 79,931 | $ | 13,300 | 8.9 | % | 8.8 | % | |||||||||||||||||||||||
45,143 | 522,759 | — | 567,902 | ||||||||||||||||||||||||||||||||||
January 2019 delivery: | |||||||||||||||||||||||||||||||||||||
Consolidated development projects | |||||||||||||||||||||||||||||||||||||
399 Binney Street/Greater Boston/Cambridge | 100% | 1/25/19 | — | — | 123,403 | 123,403 | 100% | 164,000 | $ | 174,000 | 7.3 | % | 6.7 | % | |||||||||||||||||||||||
Total | 45,143 | 522,759 | 123,403 | 691,305 | 7.5 | % | 6.9 | % | |||||||||||||||||||||||||||||
New Class A Development and Redevelopment Properties: 2019 Deliveries | ![]() | |
December 31, 2018 | ||
399 Binney Street | 266 and 275 Second Avenue | 1655 and 1725 Third Street | ||
Greater Boston/Cambridge | Greater Boston/Route 128 | San Francisco/Mission Bay/SoMa | ||
164,000 RSF | 31,858 RSF | 593,765 RSF | ||
Rubius Therapeutics, Inc. Relay Therapeutics, Inc. Celsius Therapeutics, Inc. | Blossom Innovations, LLC Multi-Tenant/Marketing | Uber Technologies, Inc. | ||
![]() | ![]() | ![]() | ||
279 East Grand Avenue | 681 Gateway Boulevard | Menlo Gateway | ||
San Francisco/South San Francisco | San Francisco/South San Francisco | San Francisco/Greater Stanford | ||
211,405 RSF | 142,400 RSF | 520,988 RSF | ||
Verily Life Sciences, LLC insitro, Inc. | Eli Lilly and Company Twist Bioscience Corporation Multi-Tenant/Marketing | Facebook, Inc. | ||
![]() | ![]() | ![]() | ||
New Class A Development and Redevelopment Properties: 2019 Deliveries | ![]() | |
December 31, 2018 | ||
Alexandria PARC | Alexandria Life Science Factory at Long Island City | 188 East Blaine Street | ||
San Francisco/Greater Stanford | New York City/New York City | Seattle/Lake Union | ||
48,547 RSF | 140,098 RSF | 198,000 RSF | ||
Adaptive Insights, Inc. | Multi-Tenant/Marketing | bluebird bio, Inc. Seattle Cancer Care Alliance Sana Biotechnology, Inc. Multi-Tenant/Marketing | ||
![]() | ![]() | |||
704 Quince Orchard Road | 5 Laboratory Drive | |
Maryland/Gaithersburg | Research Triangle Park/RTP | |
55,347 RSF | 121,477 RSF | |
Multi-Tenant/Marketing | Arysta LifeScience Inc. StrideBio, Inc. GreenLight Biosciences, Inc. | |
![]() | ![]() | |
New Class A Development and Redevelopment Properties: 2019 Deliveries (continued) | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Property/Market/Submarket | Dev/Redev | RSF | Percentage | Project Start | Occupancy(1) | ||||||||||||||||||||
In Service | Construction | Total | Leased | Leased/Negotiating | Initial | Stabilized | |||||||||||||||||||
Consolidated projects | |||||||||||||||||||||||||
266 and 275 Second Avenue/Greater Boston/Route 128 | Redev | 171,899 | 31,858 | 203,757 | 90 | % | 90 | % | 3Q17 | 1Q18 | 2019 | ||||||||||||||
5 Laboratory Drive/Research Triangle Park/RTP | Redev | 53,523 | 121,477 | 175,000 | 93 | 100 | 2Q17 | 2Q18 | 2019 | ||||||||||||||||
399 Binney Street/Greater Boston/Cambridge | Dev | — | 164,000 | (2) | 164,000 | 98 | 98 | 4Q17 | 1Q19 | 2019 | |||||||||||||||
279 East Grand Avenue/San Francisco/South San Francisco | Dev | — | 211,405 | 211,405 | 100 | 100 | 4Q17 | 1Q19 | 2020 | ||||||||||||||||
Alexandria PARC/San Francisco/Greater Stanford | Redev | 148,951 | 48,547 | 197,498 | 100 | 100 | 1Q18 | 2Q19 | 2Q19 | ||||||||||||||||
188 East Blaine Street/Seattle/Lake Union | Dev | — | 198,000 | 198,000 | 49 | 68 | 2Q18 | 2Q19 | 2020 | ||||||||||||||||
681 Gateway Boulevard/San Francisco/South San Francisco(3) | Redev | — | 142,400 | 142,400 | 89 | 97 | 3Q18 | 2Q19 | 2020 | ||||||||||||||||
Alexandria Life Science Factory at Long Island City/New York City/New York City | Redev | 36,661 | 140,098 | 176,759 | 21 | 21 | 4Q18 | 4Q19 | 2020 | ||||||||||||||||
411,034 | 1,057,785 | 1,468,819 | |||||||||||||||||||||||
Unconsolidated joint venture projects(4) | |||||||||||||||||||||||||
(amounts represent 100%) | |||||||||||||||||||||||||
704 Quince Orchard Road/Maryland/Gaithersburg | Redev | 24,584 | 55,347 | 79,931 | 44 | 48 | 1Q18 | 4Q18 | 2020 | ||||||||||||||||
Menlo Gateway/San Francisco/Greater Stanford | Dev | 251,995 | 520,988 | 772,983 | 100 | 100 | 4Q17 | 4Q19 | 4Q19 | ||||||||||||||||
1655 and 1725 Third Street/San Francisco/Mission Bay/SoMa | Dev | — | 593,765 | 593,765 | 100 | 100 | 1Q18 | 4Q19 | 4Q19 | ||||||||||||||||
276,579 | 1,170,100 | 1,446,679 | |||||||||||||||||||||||
2019 deliveries | 687,613 | 2,227,885 | 2,915,498 | 88 | % | 91 | % | ||||||||||||||||||
Our Ownership Interest | Cost to Complete | Unlevered Yields | |||||||||||||||||||||||||||||||||||
Property/Market/Submarket | In Service | CIP | Construction Loan | ARE Funding | Total at Completion | Initial Stabilized | Initial Stabilized (Cash) | ||||||||||||||||||||||||||||||
Consolidated projects | |||||||||||||||||||||||||||||||||||||
266 and 275 Second Avenue/Greater Boston/Route 128 | 100 | % | $ | 72,991 | $ | 10,568 | $ | — | $ | 5,441 | $ | 89,000 | 8.4 | % | 7.1 | % | |||||||||||||||||||||
5 Laboratory Drive/Research Triangle Park/RTP | 100 | % | 17,155 | 37,151 | — | 8,194 | 62,500 | 7.7 | 7.6 | ||||||||||||||||||||||||||||
399 Binney Street/Greater Boston/Cambridge | 100 | % | — | 160,705 | — | 13,295 | 174,000 | 7.3 | 6.7 | ||||||||||||||||||||||||||||
279 East Grand Avenue/San Francisco/South San Francisco | 100 | % | — | 98,277 | — | 52,723 | 151,000 | 7.8 | 8.1 | ||||||||||||||||||||||||||||
Alexandria PARC/San Francisco/Greater Stanford | 100 | % | 95,545 | 36,764 | — | 17,691 | 150,000 | 7.3 | 6.1 | ||||||||||||||||||||||||||||
188 East Blaine Street/Seattle/Lake Union | 100 | % | — | 97,855 | — | 92,145 | 190,000 | 6.7 | 6.7 | ||||||||||||||||||||||||||||
681 Gateway Boulevard/San Francisco/South San Francisco | 100 | % | — | 55,812 | — | 52,188 | 108,000 | 8.5 | 7.9 | ||||||||||||||||||||||||||||
Alexandria Life Science Factory at Long Island City/New York City/New York City | 100 | % | 16,986 | 61,543 | — | 105,771 | 184,300 | 5.5 | 5.6 | ||||||||||||||||||||||||||||
202,677 | 558,675 | — | 347,448 | 1,108,800 | |||||||||||||||||||||||||||||||||
Unconsolidated joint venture projects(4) | |||||||||||||||||||||||||||||||||||||
(amounts represent our share) | |||||||||||||||||||||||||||||||||||||
704 Quince Orchard Road/Maryland/Gaithersburg | 56.8 | % | 1,827 | 5,800 | 4,809 | 864 | 13,300 | 8.9 | 8.8 | ||||||||||||||||||||||||||||
Menlo Gateway/San Francisco/Greater Stanford | 38.5 | % | 100,196 | 138,452 | 92,205 | 99,147 | 430,000 | 6.9 | 6.3 | ||||||||||||||||||||||||||||
1655 and 1725 Third Street/San Francisco/Mission Bay/SoMa | 10.0 | % | — | 55,542 | 20,097 | 2,361 | 78,000 | 7.8 | 6.0 | ||||||||||||||||||||||||||||
102,023 | 199,794 | 117,111 | 102,372 | 521,300 | |||||||||||||||||||||||||||||||||
2019 deliveries | $ | 304,700 | $ | 758,469 | $ | 117,111 | $ | 449,820 | $ | 1,630,100 | 7.2 | % | 6.7 | % | |||||||||||||||||||||||
(1) | Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. |
(2) | We delivered 123,403 RSF during January 2019 to three life science entities. |
(3) | Conversion of single-tenant office space to multi-tenant office/laboratory space through redevelopment. |
(4) | See “Joint Venture Financial Information” in this Supplemental Information for additional information. |
New Class A Development and Redevelopment Properties: Projected 2020 Deliveries | ![]() | |
December 31, 2018 | ||
201 Haskins Way | 825 and 835 Industrial Road | ARE Spectrum | Campus Pointe by Alexandria | |||
San Francisco/South San Francisco | San Francisco/Greater Stanford | San Diego/Torrey Pines | San Diego/University Town Center | |||
280,000 RSF | 530,000 RSF | 87,000 RSF | 98,000 RSF | |||
![]() | ![]() | ![]() | ![]() | |||
1165 Eastlake Avenue East | 9800 Medical Center Drive | 9950 Medical Center Drive | 6 Davis Drive | 9 Laboratory Drive | ||||
Seattle/Lake Union | Maryland/Rockville | Maryland/Rockville | Research Triangle Park/RTP | Research Triangle Park/RTP | ||||
106,000 RSF | 174,640 RSF | 83,137 RSF | 200,000 RSF | 100,000 RSF | ||||
New Class A Development and Redevelopment Properties: Projected 2020 Deliveries (continued) | ![]() | |
December 31, 2018 | ||
Property/Market/Submarket | Dev/Redev | RSF | |||||||||
In Service | CIP | Total | |||||||||
2020 deliveries: consolidated projects | |||||||||||
201 Haskins Way/San Francisco/South San Francisco | Dev | — | 280,000 | 280,000 | |||||||
825 and 835 Industrial Road/Greater Stanford/San Francisco | Dev | — | 530,000 | 530,000 | |||||||
ARE Spectrum/San Diego/Torrey Pines | Dev | 336,461 | 87,000 | 423,461 | |||||||
Campus Pointe by Alexandria/San Diego/University Town Center | Dev | 1,067,847 | 98,000 | 1,165,847 | |||||||
1165 Eastlake Avenue East/Lake Union/Seattle | Dev | — | 106,000 | 106,000 | |||||||
9800 Medical Center Drive/Maryland/Rockville | Dev | — | 174,640 | 174,640 | |||||||
9950 Medical Center Drive/Maryland/Rockville | Dev | — | 83,137 | 83,137 | |||||||
6 Davis Drive/Research Triangle Park/RTP | Dev | — | 200,000 | 200,000 | |||||||
9 Laboratory Drive/Research Triangle Park/RTP | Dev | — | 100,000 | 100,000 | |||||||
2020 deliveries | 1,404,308 | 1,658,777 | 3,063,085 | ||||||||
New Class A Development and Redevelopment Properties: Summary of Pipeline | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Property/Submarket | Our Ownership Interest | Book Value | Square Footage | |||||||||||||||||||||||||
Projected Deliveries | Future | |||||||||||||||||||||||||||
2019 | 2020 | 2021–2022 | Total | |||||||||||||||||||||||||
Greater Boston | ||||||||||||||||||||||||||||
Undergoing construction or pre-construction | ||||||||||||||||||||||||||||
399 Binney Street (Alexandria Center® at One Kendall Square)/Cambridge | 100 | % | $ | 160,705 | 164,000 | — | — | — | 164,000 | |||||||||||||||||||
266 and 275 Second Avenue/Route 128 | 100 | % | 10,568 | 31,858 | — | — | — | 31,858 | ||||||||||||||||||||
325 Binney Street/Cambridge | 100 | % | 99,977 | — | — | 208,965 | (1) | — | 208,965 | |||||||||||||||||||
99 A Street/Seaport Innovation District | 97.4 | % | 35,747 | — | — | 235,000 | (2) | — | 235,000 | |||||||||||||||||||
215 Presidential Way/Route 128 | 100 | % | 5,373 | — | — | 130,000 | — | 130,000 | ||||||||||||||||||||
231 Second Avenue/Route 128 | 100 | % | 1,251 | — | — | 32,000 | — | 32,000 | ||||||||||||||||||||
Future development | ||||||||||||||||||||||||||||
Alexandria Technology Square®/Cambridge | 100 | % | 7,787 | — | — | — | 100,000 | 100,000 | ||||||||||||||||||||
100 Tech Drive/Route 128 | 100 | % | — | — | — | — | 300,000 | 300,000 | ||||||||||||||||||||
Other value-creation projects | 100 | % | 7,280 | — | — | — | 225,599 | 225,599 | ||||||||||||||||||||
328,688 | 195,858 | — | 605,965 | 625,599 | 1,427,422 | |||||||||||||||||||||||
San Francisco | ||||||||||||||||||||||||||||
Undergoing construction or pre-construction | ||||||||||||||||||||||||||||
1655 and 1725 Third Street/Mission Bay/SoMa | 10.0 | % | — | (3) | 593,765 | — | — | — | 593,765 | |||||||||||||||||||
279 East Grand Avenue/South San Francisco | 100 | % | 98,277 | 211,405 | — | — | — | 211,405 | ||||||||||||||||||||
681 Gateway Boulevard/South San Francisco | 100 | % | 55,812 | 142,400 | — | — | — | 142,400 | ||||||||||||||||||||
Menlo Gateway/Greater Stanford | 38.5 | % | — | (3) | 520,988 | — | — | — | 520,988 | |||||||||||||||||||
Alexandria PARC/Greater Stanford | 100 | % | 36,764 | 48,547 | — | — | — | 48,547 | ||||||||||||||||||||
201 Haskins Way/South San Francisco | 100 | % | 51,782 | — | 280,000 | — | — | 280,000 | ||||||||||||||||||||
825 and 835 Industrial Road/Greater Stanford | 100 | % | 137,856 | — | 530,000 | — | — | 530,000 | ||||||||||||||||||||
88 Bluxome Street/Mission Bay/SoMa | 100 | % | 177,530 | — | — | 1,070,925 | (2) | — | 1,070,925 | |||||||||||||||||||
505 Brannan Street, Phase II/Mission Bay/SoMa | 99.7 | % | 16,459 | — | — | 165,000 | — | 165,000 | ||||||||||||||||||||
960 Industrial Road/Greater Stanford | 100 | % | 82,830 | — | — | 533,000 | (2)(4) | — | 533,000 | |||||||||||||||||||
Future development | ||||||||||||||||||||||||||||
East Grand Avenue/South San Francisco | 100 | % | 5,988 | — | — | — | 90,000 | 90,000 | ||||||||||||||||||||
Other value-creation projects | 100 | % | 34,266 | — | — | 418,000 | 25,000 | 443,000 | ||||||||||||||||||||
697,564 | 1,517,105 | 810,000 | 2,186,925 | 115,000 | 4,629,030 | |||||||||||||||||||||||
New York City | ||||||||||||||||||||||||||||
Undergoing construction or pre-construction | ||||||||||||||||||||||||||||
Alexandria Life Science Factory at Long Island City – New York City/ New York City | 100 | % | 61,543 | 140,098 | — | — | — | 140,098 | ||||||||||||||||||||
Alexandria Center® for Life Science – New York City/New York City | 100 | % | 15,194 | — | — | 550,000 | — | 550,000 | ||||||||||||||||||||
Future redevelopment | ||||||||||||||||||||||||||||
219 East 42nd Street/New York City | 100 | % | — | — | — | — | 579,947 | (5) | 579,947 | |||||||||||||||||||
$ | 76,737 | 140,098 | — | 550,000 | 579,947 | 1,270,045 | ||||||||||||||||||||||
(1) We are seeking additional entitlements to at least double the density on the site from its current 208,965 RSF. (2) Represents total square footage upon completion of development of a new Class A property. RSF presented includes RSF of a building currently in operation that will be demolished upon commencement of construction. (3) This property is held by an unconsolidated real estate joint venture. See “Joint Venture Financial Information” within this Supplemental Information for additional information on our ownership interest. (4) Represents total RSF available for future development in either (i) one phase aggregating 533,000 RSF or (ii) two phases consisting of 423,000 RSF and 110,000 RSF, upon receiving entitlements. (5) Includes 349,947 RSF in operation with an opportunity to either convert the existing office space into office/laboratory space through future redevelopment or to expand the building by an additional 230,000 RSF through ground-up development. The building is currently occupied by Pfizer Inc. with a remaining lease term of six years. | ||||||||||||||||||||||||||||
New Class A Development and Redevelopment Properties: Summary of Pipeline (continued) | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Property/Submarket | Our Ownership Interest | Book Value | Square Footage | |||||||||||||||||||||||||
Projected Deliveries | Future | |||||||||||||||||||||||||||
2019 | 2020 | 2021–2022 | Total | |||||||||||||||||||||||||
San Diego | ||||||||||||||||||||||||||||
Undergoing construction or pre-construction | ||||||||||||||||||||||||||||
ARE Spectrum/Torrey Pines | 100 | % | $ | 29,698 | — | 87,000 | — | — | 87,000 | |||||||||||||||||||
Campus Pointe by Alexandria/University Town Center | (1 | ) | 82,147 | — | 98,000 | 406,455 | (2) | — | 504,455 | |||||||||||||||||||
5200 Illumina Way/University Town Center | 100 | % | 11,716 | — | — | 386,044 | — | 386,044 | ||||||||||||||||||||
Townsgate by Alexandria/Del Mar Heights | 100 | % | 17,858 | — | — | 125,000 | — | 125,000 | ||||||||||||||||||||
Future development | ||||||||||||||||||||||||||||
Campus Pointe by Alexandria/University Town Center | (1 | ) | 43,389 | — | — | — | 290,283 | (3) | 290,283 | |||||||||||||||||||
Vista Wateridge/Sorrento Mesa | 100 | % | 4,022 | — | — | — | 163,000 | 163,000 | ||||||||||||||||||||
Other value-creation projects | 100 | % | 5,931 | — | — | — | 222,895 | 222,895 | ||||||||||||||||||||
194,761 | — | 185,000 | 917,499 | 676,178 | 1,778,677 | |||||||||||||||||||||||
Seattle | ||||||||||||||||||||||||||||
Undergoing construction or pre-construction | ||||||||||||||||||||||||||||
188 East Blaine Street/Lake Union | 100 | % | 97,855 | 198,000 | — | — | — | 198,000 | ||||||||||||||||||||
1165 Eastlake Avenue East/Lake Union | 100 | % | 18,010 | — | 106,000 | — | — | 106,000 | ||||||||||||||||||||
1150 Eastlake Avenue East/Lake Union | 100 | % | 23,313 | — | — | 260,000 | — | 260,000 | ||||||||||||||||||||
701 Dexter Avenue North/Lake Union | 100 | % | 37,701 | — | — | 217,000 | — | 217,000 | ||||||||||||||||||||
176,879 | 198,000 | 106,000 | 477,000 | — | 781,000 | |||||||||||||||||||||||
Maryland | ||||||||||||||||||||||||||||
Undergoing construction or pre-construction | ||||||||||||||||||||||||||||
704 Quince Orchard Road/Gaithersburg | 56.8 | % | — | (4) | 55,347 | — | — | — | 55,347 | |||||||||||||||||||
9800 Medical Center Drive/Rockville | 100 | % | 14,116 | — | 174,640 | — | — | 174,640 | ||||||||||||||||||||
9950 Medical Center Drive/Rockville | 100 | % | 5,375 | — | 83,137 | — | — | 83,137 | ||||||||||||||||||||
Future development | ||||||||||||||||||||||||||||
9800 Medical Center Drive/Rockville | 100 | % | 1,214 | — | — | — | 64,000 | 64,000 | ||||||||||||||||||||
20,705 | 55,347 | 257,777 | — | 64,000 | 377,124 | |||||||||||||||||||||||
Research Triangle Park | ||||||||||||||||||||||||||||
Undergoing construction or pre-construction | ||||||||||||||||||||||||||||
5 Laboratory Drive/Research Triangle Park | 100 | % | 37,151 | 121,477 | — | — | — | 121,477 | ||||||||||||||||||||
6 Davis Drive/Research Triangle Park | 100 | % | 2,306 | — | 200,000 | — | — | 200,000 | ||||||||||||||||||||
9 Laboratory Drive/Research Triangle Park | 100 | % | 1,634 | — | 100,000 | — | — | 100,000 | ||||||||||||||||||||
Future development | ||||||||||||||||||||||||||||
6 Davis Drive/Research Triangle Park | 100 | % | 15,317 | — | — | — | 800,000 | 800,000 | ||||||||||||||||||||
Other value-creation projects | 100 | % | 4,149 | — | — | — | 76,262 | 76,262 | ||||||||||||||||||||
60,557 | 121,477 | 300,000 | — | 876,262 | 1,297,739 | |||||||||||||||||||||||
Other value-creation projects | 100 | % | 3,725 | — | — | — | 146,800 | 146,800 | ||||||||||||||||||||
$ | 1,559,616 | 2,227,885 | 1,658,777 | 4,737,389 | 3,083,786 | 11,707,837 | (5) | |||||||||||||||||||||
(1) | Includes current and future development projects at 9880 Campus Point Drive, 10260 Campus Point Drive, and 4161 Campus Point Court, for which our ownership interest is 100%, and land parcels adjacent to Campus Pointe by Alexandria, for which our ownership interest is 55%. |
(2) | Includes RSF of our future redevelopment and expansion opportunities at our newly acquired 10260 Campus Point Drive property. RSF presented includes 109,164 RSF of the building currently in operation that will be redeveloped and expanded into a 176,455 RSF Class A building, which is pre-leased 100% for 15 years with target delivery in 2021. |
(3) | Includes RSF of our newly acquired building at 4161 Campus Point Court. Upon expiration of the existing lease, 4161 Campus Point Court will support future development aggregating 201,900 RSF through one or more Class A buildings at our Campus Pointe by Alexandria campus. |
(4) | This property is held by an unconsolidated real estate joint venture. See “Joint Venture Financial Information” of this Supplemental Information for additional information on our ownership interest. |
(5) | Total RSF includes 970,180 RSF of buildings currently in operation that will be redeveloped or replaced with new development RSF upon commencement of future construction. See footnote 2 in “Investments in Real Estate” within this Supplemental Information for additional information. |
Construction Spending | ![]() |
December 31, 2018 | |
(Dollars in thousands, except per RSF amounts) | |
Year Ended | |||||||
Construction Spending | December 31, 2018 | ||||||
Additions to real estate – consolidated projects | $ | 927,168 | |||||
Investments in unconsolidated real estate joint ventures | 116,008 | ||||||
Contributions from noncontrolling interests | (28,275 | ) | |||||
Construction spending (cash basis)(1) | 1,014,901 | ||||||
Increase in accrued construction | 81,177 | ||||||
Construction spending | $ | 1,096,078 | |||||
Year Ending | |||||||
Projected Construction Spending | December 31, 2019 | ||||||
Development and redevelopment projects | $ | 983,000 | |||||
Investments in unconsolidated real estate joint ventures | 102,000 | ||||||
Contributions from noncontrolling interests (consolidated real estate joint ventures) | (22,000 | ) | |||||
Generic laboratory infrastructure/building improvement projects | 208,000 | (2) | |||||
Non-revenue-enhancing capital expenditures and tenant improvements | 29,000 | ||||||
Total projected construction spending | 1,300,000 | ||||||
Guidance range | $ | 1,250,000 | – | $1,350,000 | |||
Non-Revenue-Enhancing Capital Expenditures(3) | Year Ended | Recent Average per RSF(4) | ||||||||||||
December 31, 2018 | ||||||||||||||
Amount | Per RSF | |||||||||||||
Non-revenue-enhancing capital expenditures | $ | 11,740 | $ | 0.54 | $ | 0.51 | ||||||||
Tenant improvements and leasing costs: | ||||||||||||||
Re-tenanted space | $ | 25,244 | $ | 25.82 | $ | 20.81 | ||||||||
Renewal space | 17,784 | 16.02 | 12.59 | |||||||||||
Total tenant improvements and leasing costs/weighted average | $ | 43,028 | $ | 20.61 | $ | 15.49 | ||||||||
(1) | Includes revenue-enhancing projects and non-revenue-enhancing capital expenditures. |
(2) | Includes $45 million to $50 million of projected construction spending related to the replacement of an existing property at 9880 Campus Point Drive, in our University Town Center submarket, with a new Class A office/laboratory property aggregating 98,000 RSF. |
(3) | Excludes amounts that are recoverable from tenants, related to revenue-enhancing capital expenditures, or related to properties that have undergone redevelopment. |
(4) | Represents the average for a five-year period from 2014 to 2018. |
Joint Venture Financial Information | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Consolidated Real Estate Joint Ventures (controlled by us through contractual rights or majority voting rights) | Unconsolidated Real Estate Joint Ventures (controlled jointly or by our JV partners through contractual rights or majority voting rights) | |||||||||||
Property/Market/Submarket | Noncontrolling Interest Share(1) | Property/Market/Submarket | Our Ownership Share(2) | |||||||||
225 Binney Street/Greater Boston/Cambridge | 70.0 | % | 1655 and 1725 Third Street/San Francisco/Mission Bay/SoMa | 10.0 | % | |||||||
409 and 499 Illinois Street/San Francisco/Mission Bay/SoMa | 40.0 | % | Menlo Gateway/San Francisco/Greater Stanford | 38.5 | % | (3) | ||||||
1500 Owens Street/San Francisco/Mission Bay/SoMa | 49.9 | % | 1401/1413 Research Boulevard/Maryland/Rockville | 65.0 | % | (4) | ||||||
Campus Pointe by Alexandria/San Diego/University Town Center(5) | 45.0 | % | 704 Quince Orchard Road/Maryland/Gaithersburg | 56.8 | % | (4) | ||||||
9625 Towne Centre Drive/San Diego/University Town Center | 49.9 | % | ||||||||||
December 31, 2018 | |||||||||
Noncontrolling Interest Share of Consolidated Real Estate JVs | Our Share of Unconsolidated Real Estate JVs | ||||||||
Investments in real estate | $ | 524,523 | $ | 322,994 | |||||
Cash and cash equivalents | 19,532 | 5,316 | |||||||
Restricted cash | — | 79 | |||||||
Other assets | 34,835 | 24,663 | |||||||
Secured notes payable (see page 49) | — | (87,677 | ) | ||||||
Other liabilities | (26,141 | ) | (27,868 | ) | |||||
Redeemable noncontrolling interests | (10,786 | ) | — | ||||||
$ | 541,963 | $ | 237,507 | ||||||
Noncontrolling Interest Share of Consolidated Real Estate JVs | Our Share of Unconsolidated Real Estate JVs | ||||||||||||||||
4Q18 | 2018 | 4Q18 | 2018 | ||||||||||||||
Total revenues | $ | 14,556 | $ | 55,914 | $ | 2,380 | $ | 16,681 | |||||||||
Rental operations | (4,436 | ) | (17,021 | ) | (371 | ) | (4,821 | ) | |||||||||
10,120 | 38,893 | 2,009 | 11,860 | ||||||||||||||
General and administrative | (36 | ) | (208 | ) | (56 | ) | (127 | ) | |||||||||
Interest | — | — | (205 | ) | (1,010 | ) | |||||||||||
Depreciation and amortization | (4,252 | ) | (16,077 | ) | (719 | ) | (3,181 | ) | |||||||||
Gain on early extinguishment of debt | — | — | — | 761 | |||||||||||||
Gain on sales of real estate(6) | — | — | — | 35,678 | |||||||||||||
$ | 5,832 | $ | 22,608 | $ | 1,029 | $ | 43,981 | ||||||||||
(1) | In addition to the consolidated real estate joint ventures listed, various partners hold insignificant noncontrolling interests in four other joint ventures in North America. |
(2) | In addition to the unconsolidated real estate joint ventures listed, we hold one other insignificant unconsolidated real estate joint venture in North America. |
(3) | As of December 31, 2018, we have an ownership interest in Menlo Gateway of 38.5% and expect our ownership to increase to 49% through future funding of construction costs in 2019. |
(4) | Represents our ownership interest; our voting interest is limited to 50%. |
(5) | Includes only 10290 and 10300 Campus Point Drive and 4110 Campus Point Court in our University Town Center submarket. Excludes 10260 Campus Point Drive and 4161 Campus Point Court. |
(6) | Related to the sale in September 2018 of our remaining 27.5% ownership interest in the unconsolidated real estate joint venture in 360 Longwood Avenue. |
Investments | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
December 31, 2018 | ||||||||||
Three Months Ended | Year Ended | |||||||||
Realized gains | $ | 11,319 | (1) | $ | 37,129 | |||||
Unrealized (losses) gains | (94,850 | ) | 99,634 | |||||||
Investment (loss) income | $ | (83,531 | ) | $ | 136,763 | |||||
Investments | Cost | Adjustments | Carrying Amount | |||||||||||||
Fair value: | ||||||||||||||||
Publicly traded companies | $ | 121,121 | $ | 62,884 | $ | 184,005 | ||||||||||
Entities that report NAV | 204,646 | 113,159 | (2) | 317,805 | ||||||||||||
Entities that do not report NAV: | ||||||||||||||||
Entities with observable price changes since 1/1/18 | 39,421 | 64,112 | 103,533 | |||||||||||||
Entities without observable price changes | 286,921 | — | 286,921 | |||||||||||||
December 31, 2018 | $ | 652,109 | $ | 240,155 | (3) | $ | 892,264 | |||||||||
(1) | Includes realized gain of $6.4 million related to one publicly traded non-real estate investment in a biopharmaceutical entity and impairment of $5.5 million primarily related to one privately held non-real estate investment. Excluding these gains and impairments, our realized gains on non-real estate investments were $10.4 million for the three months ended December 31, 2018. |
(2) | Represents adjustments using reported NAV as a practical expedient to estimate fair value of our limited partnership investments. |
(3) | Consists of unrealized gains recognized of (i) $50 million on our investments in publicly traded companies prior to our adoption of the new accounting standard, (ii) $91 million on our investments in privately held entities that report NAV upon our adoption of the new accounting standard, and (iii) $99 million related to total equity investments subsequent to our adoption of the new accounting standard. |
Public/Private Mix (Cost) | |||
Tenant/Non-Tenant Mix (Cost) | |||
307 | $2.1M | ||
Holdings | Average Cost of Investment | ||
![]() | |
Key Credit Metrics | |
December 31, 2018 | |
Net Debt to Adjusted EBITDA(1) | Net Debt and Preferred Stock to Adjusted EBITDA(1) | |||||
Fixed-Charge Coverage Ratio(1) | Liquidity(2) | |||||
$2.4B | ||||||
(in millions) | ||||||
Availability under our $2.2 billion unsecured senior line of credit | $ | 1,992 | ||||
Cash, cash equivalents, and restricted cash | 272 | |||||
Investments in publicly traded companies | 184 | |||||
$ | 2,448 | |||||
(1) | Quarter annualized. |
(2) | As of December 31, 2018. |
![]() | |
Summary of Debt | |
December 31, 2018 | |
Fixed-Rate/Hedged Variable-Rate Debt | Unhedged Variable-Rate Debt | Total | Percentage | Weighted-Average | |||||||||||||||
Interest Rate(4) | Remaining Term (in years) | ||||||||||||||||||
Secured notes payable | $ | 587,444 | $ | 43,103 | $ | 630,547 | 11.5 | % | 4.22 | % | 3.1 | ||||||||
Unsecured senior notes payable | 4,292,293 | — | 4,292,293 | 78.4 | 4.15 | 6.4 | |||||||||||||
$2.2 billion unsecured senior line of credit | 100,000 | 108,000 | 208,000 | 3.8 | 3.07 | 5.1 | |||||||||||||
Unsecured senior bank term loan | 347,415 | — | 347,415 | 6.3 | 2.21 | 5.1 | |||||||||||||
Total/weighted average | $ | 5,327,152 | $ | 151,103 | $ | 5,478,255 | 100.0 | % | 3.99 | % | 5.9 | ||||||||
Percentage of total debt | 97 | % | 3 | % | 100 | % | |||||||||||||
(1) | Includes our secured construction loan for our property at 50 and 60 Binney Street in our Cambridge submarket with an outstanding balance of $193.1 million as of December 31, 2018. We have the option to extend the stated maturity date to January 28, 2021, subject to certain conditions. We exercised the first right to extend the maturity date to January 28, 2020. We expect to refinance this secured construction loan prior to maturity. |
(2) | We generally amend and extend our unsecured senior line of credit every two to three years. |
(3) | We expect to seek opportunities to refinance our unsecured senior bank term loan through the bond market prior to maturity. Additionally, we anticipate reducing the outstanding borrowings under our unsecured senior bank term loan over the next several years. |
(4) | Represents the weighted-average interest rate as of the end of the applicable period, including expense/income related to our interest rate hedge agreements, amortization of loan fees, amortization of debt premiums (discounts), and other bank fees. |
Summary of Debt (continued) | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Debt | Stated Rate | Interest Rate(1) | Maturity Date(2) | Principal Payments Remaining for the Periods Ending December 31, | Principal | Unamortized (Deferred Financing Cost), (Discount)/Premium | Total | ||||||||||||||||||||||||||||||||||||||||
2019 | 2020 | 2021 | 2022 | 2023 | Thereafter | ||||||||||||||||||||||||||||||||||||||||||
Secured notes payable | |||||||||||||||||||||||||||||||||||||||||||||||
Greater Boston | L+1.50 | % | 3.29 | % | 1/28/20 | (3) | $ | — | $ | 193,103 | $ | — | $ | — | $ | — | $ | — | $ | 193,103 | $ | (57 | ) | $ | 193,046 | ||||||||||||||||||||||
Greater Boston, San Diego, Seattle, and Maryland | 7.75 | % | 8.15 | 4/1/20 | (4) | 2,309 | 104,352 | — | — | — | — | 106,661 | (418 | ) | 106,243 | ||||||||||||||||||||||||||||||||
San Diego | 4.66 | % | 4.91 | 1/1/23 | 1,686 | 1,762 | 1,852 | 1,942 | 26,259 | — | 33,501 | (263 | ) | 33,238 | |||||||||||||||||||||||||||||||||
Greater Boston | 3.93 | % | 3.19 | 3/10/23 | 1,505 | 1,566 | 1,628 | 1,693 | 74,517 | — | 80,909 | 2,303 | 83,212 | ||||||||||||||||||||||||||||||||||
Greater Boston | 4.82 | % | 3.40 | 2/6/24 | 3,078 | 3,204 | 3,392 | 3,561 | 3,739 | 183,543 | 200,517 | 13,540 | 214,057 | ||||||||||||||||||||||||||||||||||
San Francisco | 6.50 | % | 6.50 | 7/1/36 | 23 | 25 | 26 | 28 | 30 | 619 | 751 | — | 751 | ||||||||||||||||||||||||||||||||||
Secured debt weighted-average interest rate/subtotal | 4.94 | % | 4.22 | 8,601 | 304,012 | 6,898 | 7,224 | 104,545 | 184,162 | 615,442 | 15,105 | 630,547 | |||||||||||||||||||||||||||||||||||
$2.2 billion unsecured senior line of credit | L+0.825 | % | 3.07 | 1/28/24 | — | — | — | — | — | 208,000 | 208,000 | — | 208,000 | ||||||||||||||||||||||||||||||||||
Unsecured senior bank term loan | L+0.90 | % | 2.21 | 1/28/24 | — | — | — | — | — | 350,000 | 350,000 | (2,585 | ) | 347,415 | |||||||||||||||||||||||||||||||||
Unsecured senior notes payable | 2.75 | % | 2.96 | 1/15/20 | — | 400,000 | — | — | — | — | 400,000 | (845 | ) | 399,155 | |||||||||||||||||||||||||||||||||
Unsecured senior notes payable | 4.60 | % | 4.75 | 4/1/22 | — | — | — | 550,000 | — | — | 550,000 | (2,115 | ) | 547,885 | |||||||||||||||||||||||||||||||||
Unsecured senior notes payable | 3.90 | % | 4.04 | 6/15/23 | — | — | — | — | 500,000 | — | 500,000 | (2,653 | ) | 497,347 | |||||||||||||||||||||||||||||||||
Unsecured senior notes payable | 4.00 | % | 4.18 | 1/15/24 | — | — | — | — | — | 450,000 | 450,000 | (3,685 | ) | 446,315 | |||||||||||||||||||||||||||||||||
Unsecured senior notes payable | 3.45 | % | 3.62 | 4/30/25 | — | — | — | — | — | 600,000 | 600,000 | (5,526 | ) | 594,474 | |||||||||||||||||||||||||||||||||
Unsecured senior notes payable | 4.30 | % | 4.50 | 1/15/26 | — | — | — | — | — | 300,000 | 300,000 | (3,414 | ) | 296,586 | |||||||||||||||||||||||||||||||||
Unsecured senior notes payable | 3.95 | % | 4.13 | 1/15/27 | — | — | — | — | — | 350,000 | 350,000 | (4,037 | ) | 345,963 | |||||||||||||||||||||||||||||||||
Unsecured senior notes payable | 3.95 | % | 4.07 | 1/15/28 | — | — | — | — | — | 425,000 | 425,000 | (3,818 | ) | 421,182 | |||||||||||||||||||||||||||||||||
Unsecured senior notes payable | 4.50 | % | 4.60 | 7/30/29 | — | — | — | — | — | 300,000 | 300,000 | (2,344 | ) | 297,656 | |||||||||||||||||||||||||||||||||
Unsecured senior notes payable | 4.70 | % | 4.81 | 7/1/30 | — | — | — | — | — | 450,000 | 450,000 | (4,270 | ) | 445,730 | |||||||||||||||||||||||||||||||||
Unsecured debt weighted average/subtotal | 3.96 | — | 400,000 | — | 550,000 | 500,000 | 3,433,000 | 4,883,000 | (35,292 | ) | 4,847,708 | ||||||||||||||||||||||||||||||||||||
Weighted-average interest rate/total | 3.99 | % | $ | 8,601 | $ | 704,012 | $ | 6,898 | $ | 557,224 | $ | 604,545 | $ | 3,617,162 | $ | 5,498,442 | $ | (20,187 | ) | $ | 5,478,255 | ||||||||||||||||||||||||||
Balloon payments | $ | — | $ | 697,082 | $ | — | $ | 550,000 | $ | 600,487 | $ | 3,616,237 | $ | 5,463,806 | $ | — | $ | 5,463,806 | |||||||||||||||||||||||||||||
Principal amortization | 8,601 | 6,930 | 6,898 | 7,224 | 4,058 | 925 | 34,636 | (20,187 | ) | 14,449 | |||||||||||||||||||||||||||||||||||||
Total debt | $ | 8,601 | $ | 704,012 | $ | 6,898 | $ | 557,224 | $ | 604,545 | $ | 3,617,162 | $ | 5,498,442 | $ | (20,187 | ) | $ | 5,478,255 | ||||||||||||||||||||||||||||
Fixed-rate/hedged variable-rate debt | $ | 8,601 | $ | 660,909 | $ | 6,898 | $ | 557,224 | $ | 604,545 | $ | 3,509,162 | $ | 5,347,339 | $ | (20,187 | ) | $ | 5,327,152 | ||||||||||||||||||||||||||||
Unhedged variable-rate debt | — | 43,103 | — | — | — | 108,000 | 151,103 | — | 151,103 | ||||||||||||||||||||||||||||||||||||||
Total debt | $ | 8,601 | $ | 704,012 | $ | 6,898 | $ | 557,224 | $ | 604,545 | $ | 3,617,162 | $ | 5,498,442 | $ | (20,187 | ) | $ | 5,478,255 | ||||||||||||||||||||||||||||
Weighted-average stated rate on maturing debt | N/A | 3.86% | N/A | 4.60% | 3.95% | 4.00% | |||||||||||||||||||||||||||||||||||||||||
(1) | Represents the weighted-average interest rate as of the end of the applicable period, including expense/income related to our interest rate hedge agreements, amortization of loan fees, amortization of debt premiums (discounts), and other bank fees. |
(2) | Reflects any extension options that we control. |
(3) | See footnote 1 on prior page. |
(4) | In January 2019, we repaid this secured note payable and recognized a loss on early extinguishment of debt of $7.1 million, including the write-off of unamortized loan fees. |
Summary of Debt (continued) | ![]() |
December 31, 2018 | |
(Dollars in thousands) | |
Unconsolidated real estate joint ventures’ debt | |||||||||||||||||||||||
100% at JV Level | |||||||||||||||||||||||
Unconsolidated Joint Venture | Our Share | Maturity Date | Stated Interest Rate | Interest Rate(1) | Debt Balance(2) | Remaining Commitments | |||||||||||||||||
1401/1413 Research Boulevard | 65.0 | % | 5/17/20 | L+2.50% | 5.87 | % | $ | 20,181 | $ | 7,435 | |||||||||||||
1655 and 1725 Third Street | 10.0 | % | 6/29/21 | L+3.70% | 6.05 | % | 168,366 | 206,634 | |||||||||||||||
704 Quince Orchard Road | 56.8 | % | 3/16/23 | L+1.95% | 4.66 | % | 4,903 | 9,940 | |||||||||||||||
Menlo Gateway, Phase II | 38.5 | % | (3) | 5/1/35 | 4.53% | N/A | — | 157,270 | |||||||||||||||
Menlo Gateway, Phase I | 38.5 | % | (3) | 8/10/35 | 4.15% | 4.18 | % | 144,338 | N/A | ||||||||||||||
$ | 337,788 | $ | 381,279 | ||||||||||||||||||||
(1) | Includes interest expense, amortization of loan fees, and amortization of premiums (discounts) as of December 31, 2018. |
(2) | Represents outstanding principal, net of unamortized deferred financing costs and premiums (discounts). |
(3) | See “Joint Venture Financial Information” within this Supplemental Information for additional information on our ownership interest. |
Debt covenants | |||||||||
Debt Covenant Ratios(1) | Unsecured Senior Notes Payable | $2.2 Billion Unsecured Senior Line of Credit and Unsecured Senior Bank Term Loan | |||||||
Requirement | December 31, 2018 | Requirement | December 31, 2018 | ||||||
Total Debt to Total Assets | ≤ 60% | 34% | ≤ 60.0% | 28.1% | |||||
Secured Debt to Total Assets | ≤ 40% | 4% | ≤ 45.0% | 3.2% | |||||
Consolidated EBITDA to Interest Expense | ≥ 1.5x | 6.3x | ≥ 1.50x | 3.99x | |||||
Unencumbered Total Asset Value to Unsecured Debt | ≥ 150% | 272% | N/A | N/A | |||||
Unsecured Interest Coverage Ratio | N/A | N/A | ≥ 1.75x | 6.19x | |||||
(1) | All covenant ratio titles utilize terms as defined in the respective debt agreements. EBITDA is not calculated pursuant to the definition set forth by the SEC in Exchange Act Release No. 47226. |
Interest rate swap agreements | |||||||||||||||||||
Effective Date | Maturity Date | Number of Contracts | Weighted-Average Interest Pay Rate(1) | Fair Value as of 12/31/18 | Notional Amount in Effect as of | ||||||||||||||
12/31/18 | 12/31/19 | ||||||||||||||||||
March 29, 2018 | March 31, 2019 | 8 | 1.16% | $ | 1,962 | $ | 600,000 | $ | — | ||||||||||
March 29, 2019 | March 31, 2020 | 1 | 1.89% | 644 | — | 100,000 | |||||||||||||
March 29, 2019 | March 31, 2020 | 3 | 2.84% | (768 | ) | — | 250,000 | ||||||||||||
Total | $ | 1,838 | $ | 600,000 | $ | 350,000 | |||||||||||||
(1) | In addition to the interest pay rate for each swap agreement, interest is payable at an applicable margin over LIBOR for borrowings outstanding as of December 31, 2018, as listed under the column heading “Stated Rate” in our summary table of outstanding indebtedness and respective principal payments on the previous page. |
![]() | |
Definitions and Reconciliations | |
December 31, 2018 | |
Three Months Ended | ||||||||||||||||||||
(Dollars in thousands) | 12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | |||||||||||||||
Net (loss) income | $ | (18,631 | ) | $ | 219,359 | $ | 60,547 | $ | 141,518 | $ | 45,607 | |||||||||
Interest expense | 40,239 | 42,244 | 38,097 | 36,915 | 36,082 | |||||||||||||||
Income taxes | 613 | 568 | 1,106 | 940 | 1,398 | |||||||||||||||
Depreciation and amortization | 124,990 | 119,600 | 118,852 | 114,219 | 107,714 | |||||||||||||||
Stock compensation expense | 9,810 | 9,986 | 7,975 | 7,248 | 6,961 | |||||||||||||||
Loss on early extinguishment of debt | — | 1,122 | — | — | 2,781 | |||||||||||||||
Our share of gain on early extinguishment of debt from unconsolidated real estate JVs | — | (761 | ) | — | — | — | ||||||||||||||
Gain on sale of real estate – rental properties | (8,704 | ) | — | — | — | — | ||||||||||||||
Our share of gain on sales of real estate from unconsolidated real estate JVs | — | (35,678 | ) | — | — | — | ||||||||||||||
Realized gains on non-real estate investments | (6,428 | ) | (1) | — | — | — | — | |||||||||||||
Unrealized losses (gains) on non-real estate investments | 94,850 | (117,188 | ) | (5,067 | ) | (72,229 | ) | — | ||||||||||||
Impairment of real estate | — | — | 6,311 | — | — | |||||||||||||||
Impairment of non-real estate investments | 5,483 | (1) | — | — | — | 3,805 | ||||||||||||||
Adjusted EBITDA | $ | 242,222 | $ | 239,252 | $ | 227,821 | $ | 228,611 | $ | 204,348 | ||||||||||
Revenues | $ | 340,463 | $ | 341,823 | $ | 325,034 | $ | 320,139 | $ | 298,791 | ||||||||||
Non-real estate investments – total realized gains | 11,319 | 5,015 | 7,463 | 13,332 | — | |||||||||||||||
Realized gains on non-real estate investments | (6,428 | ) | (1) | — | — | — | — | |||||||||||||
Impairment of non-real estate investments | 5,483 | (1) | — | — | — | 3,805 | ||||||||||||||
Revenues, as adjusted | $ | 350,837 | $ | 346,838 | $ | 332,497 | $ | 333,471 | $ | 302,596 | ||||||||||
Adjusted EBITDA margin | 69% | 69% | 69% | 69% | 68% | |||||||||||||||
(1) | Realized gain of $6.4 million relates to one publicly traded non-real estate investment in a biopharmaceutical entity and impairments of $5.5 million primarily relates to one privately held non-real estate investment. Both line items are classified in investment (loss) income in our consolidated statements of operations. Excluding these gains and impairments, our realized gains on non-real estate investments were $10.4 million for the three months ended December 31, 2018. |
![]() | |
Definitions and Reconciliations (continued) | |
December 31, 2018 | |
Three Months Ended | |||||||||||||||||||
(Dollars in thousands) | 12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | ||||||||||||||
Adjusted EBITDA | $ | 242,222 | $ | 239,252 | $ | 227,821 | $ | 228,611 | $ | 204,348 | |||||||||
Interest expense | $ | 40,239 | $ | 42,244 | $ | 38,097 | $ | 36,915 | $ | 36,082 | |||||||||
Capitalized interest | 19,902 | 17,431 | 15,527 | 13,360 | 12,897 | ||||||||||||||
Amortization of loan fees | (2,401 | ) | (2,734 | ) | (2,593 | ) | (2,543 | ) | (2,571 | ) | |||||||||
Amortization of debt premiums | 611 | 614 | 606 | 575 | 639 | ||||||||||||||
Cash interest | 58,351 | 57,555 | 51,637 | 48,307 | 47,047 | ||||||||||||||
Dividends on preferred stock | 1,155 | 1,301 | 1,302 | 1,302 | 1,302 | ||||||||||||||
Fixed charges | $ | 59,506 | $ | 58,856 | $ | 52,939 | $ | 49,609 | $ | 48,349 | |||||||||
Fixed-charge coverage ratio: | |||||||||||||||||||
– quarter annualized | 4.1x | 4.1x | 4.3x | 4.6x | 4.2x | ||||||||||||||
– trailing 12 months | 4.2x | 4.3x | 4.3x | 4.3x | 4.1x | ||||||||||||||
![]() | |
Definitions and Reconciliations (continued) | |
December 31, 2018 | |
• | Initial stabilized yield reflects rental income, including contractual rent escalations and any rent concessions over the term(s) of the lease(s), calculated on a straight-line basis. |
• | Initial stabilized yield (cash basis) reflects cash rents at the stabilization date after initial rental concessions, if any, have elapsed and our total cash investment in the property. |
• | Investments in publicly traded companies were presented at fair value in the balance sheet, with changes in fair value classified in accumulated other comprehensive income within total equity. |
• | Investments in privately held entities were generally accounted for under the cost method of accounting. |
• | Gains or losses were recognized in net income upon the sale of an investment. |
• | Investments in privately held entities required accounting under the equity method unless our interest in the entity was deemed to be so minor that we had virtually no influence over the entity’s operating and financial policies. Under the equity method of accounting, we recognized our investment initially at cost and adjusted the carrying amount of the investment to recognize our share of the earnings or losses of the investee subsequent to the date of our investment. We had no investments accounted for under the equity method as of December 31, 2017. |
• | Investments were evaluated for impairment, with other-than-temporary impairments recognized in net income. |
• | Investments in publicly traded companies are presented at fair value in the balance sheet, with changes in fair value for investments in publicly traded companies and investments in privately held entities that report NAV, and observable price changes for investments in privately held entities that do not report NAV, are recognized as unrealized gains or losses and classified as investment income in our consolidated statements of operations. |
• | Investments in privately held entities without readily determinable fair values previously accounted for under the cost method are accounted for as follows: |
• | Investments in privately held entities that report NAV are presented at fair value using NAV as a practical expedient, with changes in fair value recognized in net income. |
• | Investments in privately held entities that do not report NAV are carried at cost, adjusted for observable price changes and impairments, with changes recognized in net income. |
![]() | |
Definitions and Reconciliations (continued) | |
December 31, 2018 | |
• | One-time adjustments recognized upon adoption on January 1, 2018: |
• | For investments in publicly traded companies, reclassification of cumulative unrealized gains as of December 31, 2017, aggregating $49.8 million, from accumulated other comprehensive income to retained earnings. |
• | For investments in privately held entities without readily determinable fair values that were previously accounted for under the cost method: |
• | Adjustment of cumulative unrealized gains for investments in privately held entities that report NAV, representing the difference between fair values as of December 31, 2017, using NAV as a practical expedient, and the carrying value of the investments as of December 31, 2017, previously accounted for under the cost method, aggregating $90.8 million, with a corresponding adjustment to retained earnings. |
• | No required adjustment for investments in privately held entities that do not report NAV. The ASU requires a prospective transition approach for investments in privately held entities that do not report NAV. The Financial Accounting Standards Board clarified that it would be difficult for entities to determine the last observable transaction price existing prior to the adoption of this ASU. Therefore, unlike our investments in privately held entities that report NAV that were adjusted to reflect fair values upon adoption of the new ASU, our investments in privately held entities that do not report NAV were not included in the cumulative adjustment recorded on January 1, 2018 to adjust to fair values upon adoption. As such, any initial valuation adjustments made for investments in privately held entities that do not report NAV subsequent to January 1, 2018, as a result of future observable price changes include recognition of cumulative unrealized gains or losses equal to the difference between the carrying basis of the investment and the observable price at the date of remeasurement. |
• | Investments in privately held entities continue to require accounting under the equity method unless our interest in the entity is deemed to be so minor that we have virtually no influence over the entity’s operating and financial policies. Under the equity method of accounting, we initially recognize our investment at cost and adjust the carrying amount of the investment to recognize our share of the earnings or losses of the investee subsequent to the date of our investment. We had no investments accounted for under the equity method as of December 31, 2018. |
![]() | |
Definitions and Reconciliations (continued) | |
December 31, 2018 | |
(Dollars in thousands) | 12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | |||||||||||||||
Secured notes payable | $ | 630,547 | $ | 632,792 | $ | 776,260 | $ | 775,689 | $ | 771,061 | ||||||||||
Unsecured senior notes payable | 4,292,293 | 4,290,906 | 4,289,521 | 3,396,912 | 3,395,804 | |||||||||||||||
Unsecured senior line of credit | 208,000 | 413,000 | — | 490,000 | 50,000 | |||||||||||||||
Unsecured senior bank term loans | 347,415 | 347,306 | 548,324 | 548,197 | 547,942 | |||||||||||||||
Unamortized deferred financing costs | 31,413 | 33,008 | 33,775 | 27,438 | 29,051 | |||||||||||||||
Cash and cash equivalents | (234,181 | ) | (204,181 | ) | (287,029 | ) | (221,645 | ) | (254,381 | ) | ||||||||||
Restricted cash | (37,949 | ) | (29,699 | ) | (34,812 | ) | (37,337 | ) | (22,805 | ) | ||||||||||
Net debt | $ | 5,237,538 | $ | 5,483,132 | $ | 5,326,039 | $ | 4,979,254 | $ | 4,516,672 | ||||||||||
Net debt | $ | 5,237,538 | $ | 5,483,132 | $ | 5,326,039 | $ | 4,979,254 | $ | 4,516,672 | ||||||||||
7.00% Series D convertible preferred stock | 64,336 | 74,386 | 74,386 | 74,386 | 74,386 | |||||||||||||||
Net debt and preferred stock | $ | 5,301,874 | $ | 5,557,518 | $ | 5,400,425 | $ | 5,053,640 | $ | 4,591,058 | ||||||||||
Adjusted EBITDA: | ||||||||||||||||||||
– quarter annualized | $ | 968,888 | $ | 957,008 | $ | 911,284 | $ | 914,444 | $ | 817,392 | ||||||||||
– trailing 12 months | $ | 937,906 | $ | 900,032 | $ | 854,237 | $ | 815,178 | $ | 767,508 | ||||||||||
Net debt to Adjusted EBITDA: | ||||||||||||||||||||
– quarter annualized | 5.4 | x | 5.7 | x | 5.8 | x | 5.4 | x | 5.5 | x | ||||||||||
– trailing 12 months | 5.6 | x | 6.1 | x | 6.2 | x | 6.1 | x | 5.9 | x | ||||||||||
Net debt and preferred stock to Adjusted EBITDA: | ||||||||||||||||||||
– quarter annualized | 5.5 | x | 5.8 | x | 5.9 | x | 5.5 | x | 5.6 | x | ||||||||||
– trailing 12 months | 5.7 | x | 6.2 | x | 6.3 | x | 6.2 | x | 6.0 | x | ||||||||||
Three Months Ended | Year Ended | |||||||||||||||
(Dollars in thousands) | 12/31/18 | 12/31/17 | 12/31/18 | 12/31/17 | ||||||||||||
Net (loss) income | $ | (18,631 | ) | $ | 45,607 | $ | 402,793 | $ | 194,204 | |||||||
Equity in earnings of unconsolidated real estate joint ventures | (1,029 | ) | (376 | ) | (43,981 | ) | (15,426 | ) | ||||||||
General and administrative expenses | 22,385 | 18,910 | 90,405 | 75,009 | ||||||||||||
Interest expense | 40,239 | 36,082 | 157,495 | 128,645 | ||||||||||||
Depreciation and amortization | 124,990 | 107,714 | 477,661 | 416,783 | ||||||||||||
Impairment of real estate | — | — | 6,311 | 203 | ||||||||||||
Loss on early extinguishment of debt | — | 2,781 | 1,122 | 3,451 | ||||||||||||
Gain on sales of real estate – rental properties | (8,704 | ) | — | (8,704 | ) | (270 | ) | |||||||||
Gain on sales of real estate – land parcels | — | — | — | (111 | ) | |||||||||||
Investment loss (income) | 83,531 | — | (136,763 | ) | — | |||||||||||
Net operating income | 242,781 | 210,718 | 946,339 | 802,488 | ||||||||||||
Straight-line rent revenue | (17,923 | ) | (33,281 | ) | (93,883 | ) | (107,643 | ) | ||||||||
Amortization of acquired below-market leases | (5,350 | ) | (4,147 | ) | (21,938 | ) | (19,055 | ) | ||||||||
Net operating income (cash basis) | $ | 219,508 | $ | 173,290 | $ | 830,518 | $ | 675,790 | ||||||||
Net operating income (cash basis) – annualized | $ | 878,032 | $ | 693,160 | ||||||||||||
Net operating income (from above) | $ | 242,781 | $ | 210,718 | $ | 946,339 | $ | 802,488 | ||||||||
Revenues | $ | 340,463 | $ | 298,791 | $ | 1,327,459 | $ | 1,128,097 | ||||||||
Operating margin | 71% | 71% | 71% | 71% | ||||||||||||
![]() | |
Definitions and Reconciliations (continued) | |
December 31, 2018 | |
Development – under construction | Properties | |||
399 Binney Street | 1 | |||
279 East Grand Avenue | 1 | |||
188 East Blaine Street | 1 | |||
3 | ||||
Development – placed into service after January 1, 2017 | Properties | |||
505 Brannan Street | 1 | |||
510 Townsend Street | 1 | |||
ARE Spectrum | 3 | |||
400 Dexter Avenue North | 1 | |||
100 Binney Street | 1 | |||
213 East Grand Avenue | 1 | |||
8 | ||||
Redevelopment – under construction | Properties | |||
5 Laboratory Drive | 1 | |||
266 and 275 Second Avenue | 2 | |||
Alexandria PARC | 4 | |||
681 Gateway Boulevard | 1 | |||
Alexandria Life Science Factory at Long Island City | 1 | |||
9 | ||||
Redevelopment – placed into service after January 1, 2017 | Properties | |||
9625 Towne Centre Drive | 1 | |||
9900 Medical Center Drive | 1 | |||
2 | ||||
Acquisitions after January 1, 2017 | Properties | |||
100 Tech Drive | 1 | |||
88 Bluxome Street | 1 | |||
701 Gateway Boulevard | 1 | |||
960 Industrial Road | 1 | |||
1450 Page Mill Road | 1 | |||
219 East 42nd Street | 1 | |||
4110 Campus Point Court | 1 | |||
Summers Ridge Science Park | 4 | |||
2301 5th Avenue | 1 | |||
9704, 9708, 9712, and 9714 Medical Center Drive | 4 | |||
9920 Belward Campus Drive | 1 | |||
21 Firstfield Road | 1 | |||
50 and 55 West Watkins Mill Road | 2 | |||
10260 Campus Point Drive and 4161 Campus Point Court | 2 | |||
99 A Street | 1 | |||
Other | 1 | |||
24 | ||||
Unconsolidated real estate JVs | 6 | |||
Total properties excluded from same properties | 52 | |||
Same properties | 185 | (1) | ||
Total properties in North America as of December 31, 2018 | 237 | |||
(1) | Includes 9880 Campus Point Drive, a building we acquired in 2001. The building was occupied through January 2018 and subsequently demolished in anticipation of developing a 98,000 RSF Class A office/laboratory building. |
![]() | |
Definitions and Reconciliations (continued) | |
December 31, 2018 | |
Three Months Ended | |||||||||||||||||||
(Dollars in thousands) | 12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | ||||||||||||||
Unencumbered net operating income | $ | 213,285 | $ | 213,107 | $ | 204,843 | $ | 198,599 | $ | 181,719 | |||||||||
Encumbered net operating income | 29,496 | 28,957 | 28,283 | 29,769 | 28,999 | ||||||||||||||
Total net operating income | $ | 242,781 | $ | 242,064 | $ | 233,126 | $ | 228,368 | $ | 210,718 | |||||||||
Unencumbered net operating income as a percentage of total net operating income | 88% | 88% | 88% | 87% | 86% | ||||||||||||||
Three Months Ended | |||||||||
12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | |||||
Weighted-average interest rate for capitalization of interest | 4.01% | 4.06% | 3.92% | 3.91% | 3.89% | ||||
Three Months Ended | Year Ended | |||||||||||||||||||
(In thousands) | 12/31/18 | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | 12/31/18 | 12/31/17 | |||||||||||||
Basic shares for EPS | 106,033 | 104,179 | 101,881 | 99,855 | 95,138 | 103,010 | 91,546 | |||||||||||||
Forward Agreements | — | 462 | 355 | 270 | 776 | 311 | 517 | |||||||||||||
Series D Preferred Stock | — | 744 | — | — | — | — | — | |||||||||||||
Diluted for EPS | 106,033 | 105,385 | 102,236 | 100,125 | 95,914 | 103,321 | 92,063 | |||||||||||||
Basic shares for EPS | 106,033 | 104,179 | 101,881 | 99,855 | 95,138 | 103,010 | 91,546 | |||||||||||||
Forward Agreements | 211 | 462 | 355 | 270 | 776 | 311 | 517 | |||||||||||||
Series D Preferred Stock | — | 744 | — | 741 | — | 727 | — | |||||||||||||
Diluted for FFO | 106,244 | 105,385 | 102,236 | 100,866 | 95,914 | 104,048 | 92,063 | |||||||||||||
Basic shares for EPS | 106,033 | 104,179 | 101,881 | 99,855 | 95,138 | 103,010 | 91,546 | |||||||||||||
Forward Agreements | 211 | 462 | 355 | 270 | 776 | 311 | 517 | |||||||||||||
Series D Preferred Stock | — | — | — | — | — | — | — | |||||||||||||
Diluted for FFO, as adjusted | 106,244 | 104,641 | 102,236 | 100,125 | 95,914 | 103,321 | 92,063 | |||||||||||||